Wednesday, November 17, 2010
Print Entire 2010 Program:
|
|
SESSION 1 SCHEDULE | |
Wednesday
SESSION 1:
HEMODIALYSIS ACCESS - PART 1 (8-MINUTE TALKS)
Moderators:TBD
|
|
x | |
7:55 AM - 8:00 AM | Introduction |
Presenters(s):Larry A. Scher, MD / Thomas M. Vesely, MD | |
PART 1A: INTERVENTIONAL PROCEDURES FOR HEMODIALYSIS ACCESS | |
Moderator(s): Larry A. Scher, MD / Thomas M. Vesely, MD | |
8:00 AM - 8:08 AM | Physical Examination Of The Vascular Access |
Presenters(s):Gary A. Gelbfish, MD | |
8:09 AM - 8:17 AM | Ultrasound Guided Access Interventions |
Presenters(s):Enrico Ascher, MD | |
8:18 AM - 8:26 AM | Angiographic Evaluation And Management Of Poorly Functioning Fistulas |
Presenters(s):Jacob Cynamon, MD | |
8:27 AM - 8:35 AM | Primary Stenting Of Venous Anastomotic Stenoses |
Presenters(s):Bart L. Dolmatch, MD | |
8:36 AM - 8:44 AM | Implications Of High Radial Artery Takeoff In Vascular Access |
Presenters(s):Stanley G. Cooper, MD | |
8:45 AM - 8:53 AM | Enhancement Of Fistula Maturation |
Presenters(s):Gregg A. Miller, MD | |
8:54 AM - 9:02 AM | Pathophysiology Of Vein Injury During Fistula Maturation |
Presenters(s):Thomas F. Panetta, MD | |
9:03 AM - 9:11 AM | Salvaging The Unsalvageable Fistula |
Presenters(s):Allen J. Wiesenfeld, MD | |
9:12 AM - 9:20 AM | Percutaneous Ligation Of Accessory Veins |
Presenters(s):Bart L. Dolmatch, MD | |
9:21 AM - 9:29 AM | Incisional Thrombectomy |
Presenters(s):Theodore F. Saad, MD | |
9:30 AM - 9:38 AM | Percutaneous Management Of High-Flow Fistulas |
Presenters(s):Gregg A. Miller, MD | |
9:39 AM - 10:00 AM | Panel Discussion |
10:00 AM - 10:20 AM | Break – Visit Exhibits and Pavilions (2nd and 3rd Floors) |
PART 1B: CLINICAL PRACTICE ISSUES | |
Moderator(s): Eric K. Peden, MD / Joseph N. Shams, MD | |
10:20 AM - 10:28 AM | Pre-Procedural Laboratory Studies |
Presenters(s):Theodore F. Saad, MD | |
10:29 AM - 10:37 AM | Radiation Safety During Fluoroscopy |
Presenters(s):Evan C. Lipsitz, MD | |
10:38 AM - 10:46 AM | Management Of Contrast Allergies |
Presenters(s):Joseph N. Shams, MD | |
10:47 AM - 10:55 AM | Alternative Contrast Agents For Fistulography |
Presenters(s):Timothy A. Pflederer, MD | |
10:56 AM - 11:04 AM | Management Of Pulmonary Embolism During AV Access Interventions |
Presenters(s):Thomas M. Vesely, MD | |
11:05 AM - 11:13 AM | AV Fistula Toxicity |
Presenters(s):Richard Amerling, MD | |
11:14 AM - 11:22 AM | National Database For Vascular Access Procedures |
Presenters(s):Timothy A. Pflederer, MD | |
11:23 AM - 11:31 AM | Simulator Training For Vascular Access Interventions |
Presenters(s):Ingemar J.A. Davidson, MD, PhD, FACS | |
11:32 AM - 11:50 AM | Panel Discussion |
11:50 AM - 12:45 PM | Lunch Break – Visit Exhibits and Pavilions (2nd and 3rd Floors) |
END OF SESSION 1 | |
SESSION 2 SCHEDULE | |
Wednesday
SESSION 2:
HEMODIALYSIS ACCESS - PART 2 (8-MINUTE TALKS)
Moderators:TBD
|
|
x | |
PART 2A: HEMODIALYSIS CATHETERS AND CENTRAL VEINS | |
Moderator(s): Theodore F. Saad, MD / Bart L. Dolmatch, MD | |
12:45 PM - 12:53 PM | Hemodialysis Catheter Complications: We Can Do Better |
Presenters(s):Richard Amerling, MD | |
12:54 PM - 1:02 PM | Hemodialysis Catheter Insertion: Single Incision Technique |
Presenters(s):Sohail Contractor, MD | |
1:03 PM - 1:11 PM | Central Venous Anatomy |
Presenters(s):Thomas M. Vesely, MD | |
1:12 PM - 1:20 PM | Individualized Strategies For Successful Management Of Central Venous Stenosis |
Presenters(s):John R. Ross, Sr., MD | |
1:21 PM - 1:29 PM | Percutaneous Management Of Central Venous Stenoses |
Presenters(s):Richard J. Gray, MD, FSIR | |
1:30 PM - 1:38 PM | Surgical Management Of Central Venous Occlusion |
Presenters(s):Eric K. Peden, MD | |
1:39 PM - 1:47 PM | HeRo Device: Indications And Outcomes |
Presenters(s):Marc H. Glickman, MD | |
1:48 PM - 2:10 PM | Panel Discussion |
PART 2B: NEW TECHNOLOGY | |
Moderator(s): Thomas M. Vesely, MD / Larry A. Scher, MD | |
2:10 PM - 2:18 PM | Does Integrated Ringed Support Benefit Dialysis Access Grafts? |
Presenters(s):Mitchell L. Henry, MD | |
2:19 PM - 2:27 PM | Clinical Experience With A Self-Sealing Vascular Graft For Early Cannulation |
Presenters(s):Marc H. Glickman, MD | |
2:28 PM - 2:36 PM | Initial Experience With A Unique A-V Graft Designed To Minimize Venous Outflow Complications |
Presenters(s):Charles B. Moomey, MD | |
2:37 PM - 2:45 PM | Improved Hemodynamics With The Gore Hybrid Vascular Access Graft |
Presenters(s):Eric K. Peden, MD | |
2:46 PM - 2:54 PM | AV Fistula Creation Using The Optiflow Vascular Anastomosis Device |
Presenters(s):Prabir Roy-Chaudhury, MD, PhD | |
2:55 PM - 3:03 PM | Use Of Viabahn Stent Grafts For Vascular Access Creation |
Presenters(s):John R. Ross, Sr., MD | |
3:04 PM - 3:12 PM | Clinical Experience With The Spiral Flow Vascular Access Graft |
Presenters(s):John Dick, MBChB | |
3:13 PM - 3:30 PM | Panel Discussion |
3:30 PM - 3:50 PM | Break – Visit Exhibits and Pavilions (2nd and 3rd Floors) |
PART 2C: UPDATE ON SURGICAL PROCEDURES IN HEMODIALYSIS ACCESS | |
Moderator(s): Marc H. Glickman, MD / Mitchell L. Henry, MD | |
3:50 PM - 3:58 PM | Update On Outcomes Of Fistula vs. Graft For Hemodialysis Access |
Presenters(s):Timothy A. Pflederer, MD | |
3:59 PM - 4:07 PM | Secondary Fistulas |
Presenters(s):Mitchell L. Henry, MD | |
4:08 PM - 4:16 PM | Vascular Access In The Morbidly Obese Patient |
Presenters(s):Raymond J. Holmes, MD | |
4:17 PM - 4:25 PM | Use Of Ultrasound Guided Liposuction For Superficialization Of AV Fistulas |
Presenters(s):Niten Singh, MD | |
4:26 PM - 4:34 PM | New Techniques To Maintain Vascular Access Sites |
Presenters(s):Toufic Safa, MD | |
4:35 PM - 4:43 PM | Surgical Management Of The Aneurysmal Fistula |
Presenters(s):John R. Ross, Sr., MD | |
4:44 PM - 4:52 PM | Banding vs. DRIL vs. Proximalization For Treatment Of Steal Syndrome |
Presenters(s):Larry A. Scher, MD | |
4:53 PM - 5:10 PM | Panel Discussion |
5:10 PM - 5:10 PM | Hemodialysis Access Program Adjourns |
END OF SESSION 2 | |
SESSION 3 SCHEDULE | |
Wednesday
SESSION 3:
NEW HORIZONS IN CARDIOVASCULAR SURGERY: MANAGEMENT OF AORTIC DISEASE (PART 1)
Moderators:TBD
|
|
x | |
9:50 AM - 10:00 AM | Introduction |
Presenters(s):Roy K. Greenberg, MD / Lars G. Svensson, MD, PhD | |
Moderator(s): Roy K. Greenberg, MD / Lars G. Svensson, MD, PhD | |
10:00 AM - 11:00 AM | Case Presentations And Audience Discussion |
11:00 AM - 11:15 AM | Why Do Dissections Occur? |
Presenters(s):Roy K. Greenberg, MD | |
11:15 AM - 11:30 AM | Classification System |
Presenters(s):Lars G. Svensson, MD, PhD | |
11:30 AM - 12:00 PM | Genetics Of Aortic Aneurysm Disease |
Presenters(s):Harry C. Dietz, MD | |
12:00 PM - 12:45 PM | Lunch Break – Visit Exhibits and Pavilions (2nd and 3rd Floors) |
END OF SESSION 3 | |
SESSION 4 SCHEDULE | |
Wednesday
SESSION 4:
NEW HORIZONS IN CARDIOVASCULAR SURGERY: MANAGEMENT OF AORTIC DISEASE (PART 2)
Moderators:TBD
|
|
x | |
PART 2A: RESIDUAL ARCH DISSECTION MANAGEMENT | |
Moderator(s): Lars G. Svensson, MD, PhD | |
12:45 PM - 1:15 PM | Case Presentations |
1:15 PM - 1:30 PM | The Gold Standard For Acute Proximal Dissections: Conventional Operative Approach – Is There A Reason To Evolve? |
Presenters(s):Joseph S. Coselli, MD | |
1:30 PM - 1:45 PM | Debate: Arch Repair Should Be Done At The Time Of Initial Ascending Repair |
Presenters(s):Eric E. Roselli, MD | |
1:45 PM - 2:00 PM | Debate: Arch Repair Should Not Be Done At The Time Of Initial Ascending Repair |
Presenters(s):Douglas R. Johnston, MD | |
2:00 PM - 2:15 PM | Malperfusion After Proximal Dissections |
Presenters(s):Michael D. Dake, MD | |
2:15 PM - 2:30 PM | ETG Procedure For Chronic Dissection |
Presenters(s):Lars G. Svensson, MD, PhD | |
2:30 PM - 2:45 PM | Hybrid Arch Repair Outcomes |
Presenters(s):Alan B. Lumsden, MD, FACS | |
2:45 PM - 3:15 PM | Break – Visit Exhibits and Pavilions (2nd and 3rd Floors) |
PART 2B: CHRONIC DISTAL DISSECTION | |
Moderator(s): Lars G. Svensson, MD, PhD / Richard P. Cambria, MD | |
3:15 PM - 3:45 PM | Case Presentations |
3:45 PM - 4:00 PM | Follow-up Paradigms For Stable Aortic Dissection: Objectives, Goals And Scientific Evidence |
Presenters(s):Mark F. Fillinger, MD | |
4:00 PM - 4:15 PM | Review Of Published Outcomes Of Surgical Repair Of Chronic Dissection |
Presenters(s):Tara M. Mastracci, MD | |
4:15 PM - 4:30 PM | Review Of Published Outcomes Of Endovascular Repair Of Chronic Dissection |
Presenters(s):Matthew J. Eagleton, MD | |
4:30 PM - 4:40 PM | Debate: Is There A Role For Endovascular Repair Of Chronic Dissections: Stent Graft To The Celiac |
Presenters(s):Mark A. Farber, MD | |
4:40 PM - 4:50 PM | Debate: Is There A Role For Endovascular Repair Of Chronic Dissections: Total Aortic Repair With Branched Graft |
Presenters(s):Roy K. Greenberg, MD | |
4:50 PM - 5:00 PM | Debate: Is There A Role For Endovascular Repair Of Chronic Dissections: Endovascular Repair Of Chronic Distal Dissections Is Heresy |
Presenters(s):Hazim J. Safi, MD | |
5:00 PM - 5:15 PM | Spinal Cord Ischemia: Are There Specific Dissection Issues? |
Presenters(s):Randall B. Griepp, MD | |
5:15 PM - 5:15 PM | Adjourn for the day. New Horizons in Cardiovascular Surgery continues on Thursday morning in the Grand Ballroom, 3rd Floor. |
END OF SESSION 4 | |
SESSION 5 SCHEDULE | |
Wednesday
SESSION 5:
ENDOVENOUS MANAGEMENT OF VARICOSE VEINS - PART 1 (9-MINUTE TALKS)
|
|
x | |
8:00 AM - 8:09 AM | Welcome – Endovascular Venous Surgery At A Glance |
Presenters(s):Jose I. Almeida, MD, FACS, RVT | |
8:10 AM - 8:19 AM | How Should We Approach The “Comparative Effectiveness” Issue? Do Our Interventions Affect The Progression Of Disease? Can The Registries Organized By The American Venous Forum Help? |
Presenters(s):Mark H. Meissner, MD | |
8:20 AM - 8:29 AM | Accepted Anatomical Nomenclature And Preoperative Duplex Mapping |
Presenters(s):Neil M. Khilnani, MD | |
8:30 AM - 8:39 AM | Debate – Pro: The Origin Of Saphenous Reflux Is Descending (Traditional Theory) |
Presenters(s):Bo G. Eklof, MD, PhD | |
8:40 AM - 8:49 AM | Debate – Con: The Origin Of Saphenous Reflux Is Descending (Traditional Theory) |
Presenters(s):Paul Pittaluga, MD | |
8:50 AM - 8:59 AM | Endovenous Thermal Ablation: Technical Pearls For Great And Small Saphenous Trunks |
Presenters(s):Edward G. Mackay, MD | |
9:00 AM - 9:09 AM | Endovenous Thermal Ablation: Technical Pearls For Complex Anatomy |
Presenters(s):Jose I. Almeida, MD, FACS, RVT | |
9:10 AM - 9:19 AM | Can Saphenous And Sural Nerve Paresthesia Be Prevented? |
Presenters(s):Jean Luc Gerard, MD | |
9:20 AM - 9:29 AM | Technical Pearls For Optimizing Sclerotherapy |
Presenters(s):John Mauriello, MD | |
9:30 AM - 9:39 AM | Technical Pearls For Optimizing Office-Based Phlebectomy |
Presenters(s):Paul Pittaluga, MD | |
9:40 AM - 9:49 AM | Which One: Phlebectomy, Trivex, Or Sclerotherapy For Bulging Varicose Vein Tributaries? |
Presenters(s):Marc A. Passman, MD | |
9:50 AM - 9:59 AM | Should Adjuvant Procedures Be Performed At The Same Time As Endothermal Ablation? Evidence Based |
Presenters(s):Peter J. Pappas, MD | |
10:00 AM - 10:09 AM | Review Of Randomized Controlled Trials Comparing Endovenous Thermal Ablation With Modern Extirpation Surgery For Saphenous Incompetence |
Presenters(s):Cees H.A. Wittens, MD, PhD | |
10:10 AM - 10:19 AM | Which Imaging Techniques Can Help Doctors Better Understand The Pathologic Relationships Between The Superficial And Deep Systems? |
Presenters(s):Barry Stein, MD, FSIR, FACR | |
10:20 AM - 10:29 AM | Advanced Venous Disease? Think Pelvic Outflow Obstruction |
Presenters(s):Seshadri Raju, MD | |
10:30 AM - 10:39 AM | How To Treat Chronic Venous Obstructions At Inguinal Ligament Location: Should We Choose Endovascular Technique Or Surgical Technique? |
Presenters(s):Anthony J. Comerota, MD, FACS, FACC | |
10:40 AM - 10:49 AM | Other Pelvic Venous Syndromes |
Presenters(s):Mark H. Meissner, MD | |
10:50 AM - 10:59 AM | 5 Technical Pearls For Endovascular Venous Stenting |
Presenters(s):David L. Gillespie, MD | |
11:00 AM - 11:09 AM | Debate – Pro: Only C4, C5, C6 Refluxing Truncal Veins Indicate Medical Necessity; Thus An Insurance Covered Expense |
Presenters(s):Mark A. Adelman, MD | |
11:10 AM - 11:19 AM | Debate – Con: Only C4, C5, C6 Refluxing Truncal Veins Indicate Medical Necessity; Thus An Insurance Covered Expense |
Presenters(s):Eberhard Rabe, MD | |
11:20 AM - 11:29 AM | Natural History And Progression Of DVT: How To Prevent And Treat Post-Thrombotic Syndrome |
Presenters(s):Mark H. Meissner, MD | |
11:30 AM - 11:39 AM | When To Place And Retrieve A Vena Cava Filter: Timing And Follow-up Strategy |
Presenters(s):Anthony J. Comerota, MD, FACS, FACC | |
11:40 AM - 11:49 AM | Why Vascular Surgeons Should Join The American Venous Forum |
Presenters(s):Peter J. Pappas, MD | |
11:50 AM - 11:59 AM | Current Statistics From American Venous Forum Screening Program: If We Find More Disease Can Society Pay For It? |
Presenters(s):Marc A. Passman, MD | |
12:00 PM - 12:29 PM | Luncheon Panel |
Panelist(s): Jose I. Almeida, MD, FACS, RVT / Mark A. Adelman, MD / Anthony J. Comerota, MD, FACS, FACC / Bo G. Eklof, MD, PhD / David L. Gillespie, MD / Edward G. Mackay, MD / Mark H. Meissner, MD / Peter J. Pappas, MD / Eberhard Rabe, MD / Seshadri Raju, MD / Cees H.A. Wittens, MD, PhD | |
END OF SESSION 5 | |
SESSION 6 SCHEDULE | |
Wednesday
SESSION 6:
ENDOVENOUS MANAGEMENT OF VARICOSE VEINS - PART 2 (9-MINUTE TALKS)
|
|
x | |
12:30 PM - 12:39 PM | Venous Laser Updates: Long Wavelengths Allow Usage Of Less Power And Lower Energy Density |
Presenters(s):Jose I. Almeida, MD, FACS, RVT | |
12:40 PM - 12:49 PM | Venous Laser Updates: New Fibers Allow Usage Of More Power And More Energy Density With Short Wavelengths |
Presenters(s):Lowell S. Kabnick, MD, FACS, FACPh | |
12:50 PM - 12:59 PM | Any Updates With Radiofrequency Thermal Ablation? |
Presenters(s):Alan M. Dietzek, MD, FACS, RPVI | |
1:00 PM - 1:09 PM | Is There A Common Theme For Endovenous Thermal Ablation Failure? |
Presenters(s):Peter Gloviczki, MD | |
1:10 PM - 1:19 PM | Foam Sclerotherapy: Is It Dangerous? |
Presenters(s):Alun H. Davies, MA, DM, FRCS, FHEA | |
1:20 PM - 1:29 PM | Complications Of Foam Sclerotherapy: What I Have Witnessed And How To Avoid Them |
Presenters(s):Ronald G. Bush, MD | |
1:30 PM - 1:39 PM | Using Different Gases For Foam Sclerotherapy: The Pros And The Cons |
Presenters(s):Edward G. Mackay, MD | |
1:40 PM - 1:49 PM | Ileofemoral Deep Vein Thrombosis: Catheter-Directed Thrombolysis Or Pharmacomechanical Treatment? |
Presenters(s):Anthony J. Comerota, MD, FACS, FACC | |
1:50 PM - 1:59 PM | Thrombophilia For Dummies: When To Order? What To Order? How To Treat And For How Long? |
Presenters(s):Timothy K. Liem, MD | |
2:00 PM - 2:09 PM | How To Treat Ascending GSV Superficial Thrombophlebitis |
Presenters(s):Thomas W. Wakefield, MD | |
2:10 PM - 2:19 PM | Should We Treat Calf Vein DVT? Evidence Based |
Presenters(s):Cees H.A. Wittens, MD, PhD | |
2:20 PM - 2:29 PM | Thrombus Extensions At The SFJ After Endovenous Thermal Ablation: Should We Worry? |
Presenters(s):Lowell S. Kabnick, MD, FACS, FACPh | |
2:30 PM - 2:39 PM | Recurrent Varicose Veins: Can They Be Prevented? Can They Be Treated Effectively? |
Presenters(s):Ronald G. Bush, MD | |
2:40 PM - 2:49 PM | Are Perforating Veins Being Overtreated? |
Presenters(s):Thomas F. O'Donnell, Jr., MD | |
2:50 PM - 2:59 PM | Issues On Ulcer Healing |
Presenters(s):William A. Marston, MD | |
3:00 PM - 3:09 PM | Patient Satisfaction Depends On Proper Management Of Patient Expectations: Let’s Take Spider Telangiectasia Treatment For Example |
Presenters(s):Steve Elias, MD | |
3:10 PM - 3:19 PM | Randomized Trial Comparing RF, Laser, Foam Sclerotherapy And Stripping In Varicose Veins |
Presenters(s):Lars H. Rasmussen, MD, DMSc | |
3:20 PM - 3:29 PM | Pharmacomechanical Saphenous Vein Ablation: 1-Year Data |
Presenters(s):Steve Elias, MD | |
3:30 PM - 3:39 PM | Terminal Interruption Of The Reflulx Source: TIRS Technique For Venous Ulcers |
Presenters(s):Ronald G. Bush, MD | |
3:40 PM - 4:00 PM | Ask The Panel |
Panelist(s): Jose I. Almeida, MD, FACS, RVT / Lowell S. Kabnick, MD, FACS, FACPh / Ronald G. Bush, MD / Anthony J. Comerota, MD, FACS, FACC / Alun H. Davies, MA, DM, FRCS, FHEA / Steve Elias, MD / Timothy K. Liem, MD / Edward G. Mackay, MD / William A. Marston, MD / Thomas F. O'Donnell, Jr., MD / Lars H. Rasmussen, MD, DMSc | |
4:00 PM - 4:00 PM | Adjourn. Visit Exhibits and Pavilions (2nd and 3rd Floors) |
END OF SESSION 6 | |
SESSION 7 SCHEDULE | |
Wednesday
SESSION 7:
WOUNDS - PART 1
Moderators:TBD
|
|
x | |
8:00 AM - 8:10 AM | Opening Remarks |
Presenters(s):Dieter O. Mayer, MD | |
PART 1A: NEW CONCEPTS IN WOUND CARE | |
Moderator(s): Dieter O. Mayer, MD | |
8:10 AM - 8:20 AM | Treatment Of Pyoderma Gangraenosum With Immunosuppression And A Bi-Layered Skin Substitute |
Presenters(s):Charles A. La Rosa, MD | |
8:20 AM - 8:30 AM | Discussion |
8:30 AM - 8:40 AM | Effectiveness, Tolerance And Safety Of Electrotherapy With The WoundEL System In Hard-To-Heal Wounds |
Presenters(s):Sebastian E. Debus, MD, PhD | |
8:40 AM - 8:50 AM | Discussion |
8:50 AM - 9:00 AM | Treatment Of Split Thickness Skin Graft Donor Sites |
Presenters(s):Severin Laeuchli, MD | |
9:00 AM - 9:10 AM | Discussion |
9:10 AM - 9:20 AM | Role Of Keratinocytes In Healing Of Chronic Wounds |
Presenters(s):Marjana Tomic-Canic, RN, PhD | |
9:20 AM - 9:30 AM | Discussion |
9:30 AM - 10:00 AM | Break – Visit Exhibits and Pavilions (2nd and 3rd Floors) |
PART 1B: MEETINGS SUMMARY | |
Moderator(s): Giacomo Clerici, MD | |
10:00 AM - 10:30 AM | Best From APWCA Meeting 2010 |
Presenters(s):Steven R. Kravitz, DPM | |
10:30 AM - 10:45 AM | Discussion |
10:45 AM - 11:15 AM | Best From DFCON Meeting |
Presenters(s):David G. Armstrong, DPM, MD, PhD | |
11:15 AM - 11:30 AM | Discussion |
PART 1C: WOUND HEALING SOCIETIES | |
Moderator(s): Steven R. Kravitz, DPM | |
11:30 AM - 11:40 AM | Introducing The National Pressure Ulcer Advisory Panel (NPUAP) |
Presenters(s):Laura E. Edsberg, PhD | |
11:40 AM - 11:50 AM | Discussion |
11:50 AM - 1:00 PM | Lunch Break – Visit Exhibits and Pavilions (2nd and 3rd Floors) |
END OF SESSION 7 | |
SESSION 8 SCHEDULE | |
Wednesday
SESSION 8:
WOUNDS - PART 2
Moderators:TBD
|
|
x | |
PART 2A: EVIDENCE BASED MEDICINE IN WOUND CARE | |
Moderator(s): Dieter O. Mayer, MD | |
1:00 AM - 1:10 AM | Evidence Based Medicine In Vascular Surgery And Wound Care |
Presenters(s):Dink A. Legemate, MD | |
1:10 PM - 1:20 PM | Discussion |
1:20 PM - 1:30 PM | Threats Like Selection Bias And Performance Bias |
Presenters(s):Dirk T. Ubbink, MD | |
1:30 PM - 1:40 PM | Threats Like Publication Bias And Citation Bias |
Presenters(s):Hester Vermeulen, PhD | |
1:40 PM - 2:00 PM | Discussion |
2:00 PM - 2:10 PM | Improving Research In Wound Care |
Presenters(s):Johann Steurer, MD | |
2:10 PM - 2:20 PM | RCT On Wound Care, With Good Randomization, Allocation Concealment And Blinding |
Presenters(s):Andrea Nelson, PhD | |
2:20 PM - 2:30 PM | Patient Relevant Outcomes And Surrogate Outcomes |
Presenters(s):David J. Margolis, MD, PhD | |
2:30 PM - 2:40 PM | Ischemic Wounds As An Endpoint In Clinical Trials |
Presenters(s):William R. Hiatt, MD | |
2:40 PM - 3:00 PM | Discussion |
3:00 PM - 3:10 PM | Break – Visit Exhibits and Pavilions (2nd and 3rd Floors) |
PART 2B: SPECIAL TOPICS OF INTEREST FOR THE VASCULAR SURGEON INVOLVED IN WOUND HEALING | |
Moderator(s): Joseph L. Mills, MD | |
3:10 PM - 3:20 PM | Compression In Venous Leg Ulcers: How To Increase Patient Compliance |
Presenters(s):Jürg Hafner, MD | |
3:20 PM - 3:30 PM | Surgical Approach To Wounds Prior To Vascular Intervention: When Is It Indicated? |
Presenters(s):Giacomo Clerici, MD | |
3:30 PM - 3:40 PM | Surrounding Skin Care In Vascular Ulcers |
Presenters(s):Marco Romanelli, MD, PhD | |
3:40 PM - 3:50 PM | Offloading: State-Of-The-Art |
Presenters(s):Thomas Boeni, MD | |
3:50 PM - 4:00 PM | Semmes Weinstein Monofilament: An Effective Screening Tool And Predictor Of Foot Ulceration And Amputation In Patients With Diabetes |
Presenters(s):Bauer E. Sumpio, MD, PhD | |
4:00 PM - 4:10 PM | Perioperative Blood Sugar Control: Is Less More? |
Presenters(s):Michael E. Edmonds, MD | |
4:10 PM - 4:30 PM | Panel Discussion |
PART 2C: VASCULAR INTERVENTIONS IN WOUND CARE | |
Moderator(s): Bauer E. Sumpio, MD, PhD | |
4:30 PM - 4:40 PM | Debate: Diabetic Foot Ulcers: Surgical Bypass Is More Effective |
Presenters(s):Richard F. Neville, MD | |
4:40 PM - 4:50 PM | Debate: Diabetic Foot Ulcers: Endovascular Treatment Is More Effective |
Presenters(s):Gunnar Tepe, MD | |
4:50 PM - 5:00 PM | Discussion |
5:00 PM - 5:10 PM | Lifesaving Combination Of Vascular And Plastic Surgery For Treatments Of Large Tissue Defects In Cancer Patients |
Presenters(s):Werner Lang, MD | |
5:10 PM - 5:20 PM | Discussion |
5:20 PM - 5:30 PM | Mixed Ulcers: Venous Ablation Or Arterial Reconstruction First? |
Presenters(s):Joseph L. Mills, MD | |
5:30 PM - 5:40 PM | Discussion |
5:40 PM - 5:50 PM | A New Minimally Invasive, Fast-Track Way To Compute Peripheral Vascular Anastomosis |
Presenters(s):Gabriel Szendro, MD | |
5:50 PM - 6:00 PM | Discussion |
6:00 PM - 6:10 PM | Closing Remarks |
Presenters(s):Dieter O. Mayer, MD | |
6:10 PM - 6:10 PM | WOUNDS Program Adjourns |
END OF SESSION 8 | |
SESSION 9 SCHEDULE | |
Wednesday
SESSION 9:
ACUTE STROKE MANAGEMENT - PART 1
Moderators:TBD
|
|
x | |
7:50 AM - 8:00 AM | Welcome And Introduction |
Presenters(s):Allan L. Brook, MD | |
PART 1A: THE BASICS: STROKE DIAGNOSIS AND MANAGEMENT FUNDAMENTALS | |
Moderator(s): Allan L. Brook, MD / Joshua A. Hirsch, MD | |
8:00 AM - 8:10 AM | Stroke Classics: Correlating Clinical Presentation With Imaging: Highlighting The Cerebrovascular Territories |
Presenters(s):Lou Caplan, MD | |
8:11 AM - 8:21 AM | TIAs - Transient Ischemic Attacks: Do We Need Better Classification And Treatment Triage Schemes? |
Presenters(s):Lawrence Wechsler, MD | |
8:22 AM - 8:32 AM | Hypoperfusion Syndromes: Diagnosis, Science, And Treatment Options |
Presenters(s):Colin P. Derdeyn, MD | |
8:33 AM - 8:43 AM | Differential Diagnosis Of Stroke: How We Expedite The Diagnosis And Treatment Pathways |
Presenters(s):Daniel Labovitz, MD | |
8:44 AM - 8:54 AM | Triage Is The Holy Grail; Door To Revascularization Time: What Is The Standard To Be Set? |
Presenters(s):Edward C. Jauch, MD, MS | |
8:55 AM - 9:10 AM | Discussion |
PART 1B: STATE-OF-THE-ART IMAGING FOR CEREBROVASCULAR DISEASE AND STROKE | |
Moderator(s): Howard A. Rowley, MD / Lawrence Wechsler, MD | |
9:11 AM - 9:21 AM | The Standard Neuroimaging Protocol: What , When And Why? |
Presenters(s):Howard A. Rowley, MD | |
9:22 AM - 9:32 AM | Update On Latest Trials: Is There Any New Science To Guide Us On Which Patients Will Benefit From Revascularization? |
Presenters(s):Lawrence Wechsler, MD | |
9:33 AM - 9:43 AM | Debating The Pros And Cons Of CT(A/P) vs. MR(A/P) |
Presenters(s):Todd S. Miller, MD | |
9:44 AM - 9:54 AM | Stroke Imaging Pearls: Sequences To Help In Difficult Cases |
Presenters(s):Meng Law, MD | |
PART 1C: STATE-OF-THE-ART TRIAGE FOR STROKE PATIENTS (5-MINUTE TALKS) | |
Moderator(s): Lawrence Wechsler, MD / Howard A. Rowley, MD | |
9:55 AM - 10:00 AM | State-Of-The-Art Triage: My Best Asset Is The Clinical Exam |
Presenters(s):H. Christian Weston-Schumacher, MD | |
10:01 AM - 10:06 AM | State-Of-The-Art Triage: My Best Asset Is Neuroimaging |
Presenters(s):Howard A. Rowley, MD | |
10:07 AM - 10:12 AM | State-Of-The-Art Triage: My Best Asset Is My Institution |
Presenters(s):Steven H. Rudolph, MD | |
10:13 AM - 10:30 AM | Discussion |
10:30 AM - 11:00 AM | Break – Visit Exhibits and Pavilions (2nd and 3rd Floors) |
PART 1D: ACCEPTANCE OF CAROTID STENTING OR IS IT MORE OF THE SAME? | |
Moderator(s): Charles J. Prestigiacomo, MD / Aman Patel, MD | |
11:01 AM - 11:11 AM | CREST: What Are The Implications And Why? |
Presenters(s):Thomas G. Brott, MD | |
11:12 AM - 11:22 AM | Symptomatic Carotid Disease: How I Choose Between CEA And CAS |
Presenters(s):Charles J. Prestigiacomo, MD | |
11:23 AM - 11:33 AM | Asymptomatic Carotid Disease: When To Treat And Why |
Presenters(s):Thomas G. Brott, MD | |
11:34 AM - 11:44 AM | Carotid Blowout Syndromes: Cancer To Trauma; Endovascular Options |
Presenters(s):Gregg H. Zoarski, MD | |
11:45 AM - 12:00 PM | Discussion |
PART 1E: BUILDING A COMPREHENSIVE STROKE CENTER: EXCELLENCE DEFINED BY TECHNOLOGY, MANPOWER, AND MANAGEMENT | |
Moderator(s): Thomas G. Brott, MD / H. Christian Weston-Schumacher, MD | |
12:01 PM - 12:11 PM | Telemedicine: Its Role, Its Risk, And Its Intricacies |
Presenters(s):Mitchell J. Rubin, MD | |
12:12 PM - 12:22 PM | Neurological Intensive Care: Best Practice, Benefits, And Cost; Defining A Standard! |
Presenters(s):Matthew E. Fink, MD | |
12:23 PM - 12:39 PM | Discussion |
END OF SESSION 9 | |
SESSION 10 SCHEDULE | |
Wednesday
SESSION 10:
ACUTE STROKE MANAGEMENT - PART 2
Moderators:TBD
|
|
x | |
PART 2A: LUNCHEON SESSION: ACUTE STROKE TREATMENT OPTIONS 2010: INTRAVENOUS VS. INTRAARTERIAL - WHAT DO YOU PREFER? | |
Moderator(s): Peter K. Nelson, MD / Joshua A. Hirsch, MD | |
12:40 PM - 12:50 PM | Intravenous: Latest Guidelines |
Presenters(s):Steven H. Rudolph, MD | |
12:51 PM - 1:01 PM | Intraarterial Options: Are There Guidelines? |
Presenters(s):Raul G. Nogueria, MD | |
1:02 PM - 1:12 PM | Current IA Protocols For Reperfusion: Update |
Presenters(s):Osama O. Zaidat, MD | |
1:13 PM - 1:23 PM | Angioplasty, Stenting And Temporary Stenting: State-Of--The-Art Technology And Where We Are Headed |
Presenters(s):David Fiorella, MD | |
1:24 PM - 1:40 PM | Discussion |
PART 2B: INTRACRANIAL ATHEROSCLEROSIS: DIAGNOSIS AND MANAGEMENT | |
Moderator(s): Philip M. Meyers, MD / Lou Caplan, MD | |
1:41 PM - 1:51 PM | Natural History Of Intracranial Atherosclerosis |
Presenters(s):Lou Caplan, MD | |
1:52 PM - 2:02 PM | Therapeutic Options For Intracranial Stenosis: Medical, Interventional, And Surgical Guidelines |
Presenters(s):Philip M. Meyers, MD | |
2:03 PM - 2:13 PM | SAMMPRIS Update |
Presenters(s):Marc Chimowitz, MD | |
2:14 PM - 2:34 PM | Discussion |
PART 2C: STROKE: HOT TOPICS AND CASE PRESENTATIONS WITH FIERCE DISCUSSION! | |
Moderator(s): Allan L. Brook, MD / Aquilla S. Turk, DO | |
2:35 PM - 2:45 PM | Slam Dunk IA Revascularization: The Case For The Pharmacologic Approach |
Presenters(s):Raul G. Nogueria, MD | |
2:46 PM - 2:56 PM | Slam Dunk IA Revascularization: The Case For Thrombectomy |
Presenters(s):Don Frei, MD | |
2:57 PM - 3:07 PM | The Case I Should Not Have Chosen IA Therapy And Why: Identifying Nasty Anatomy And Pathology To Avoid |
Presenters(s):Aquilla S. Turk, DO | |
3:08 PM - 3:18 PM | Identifying Normal Vascular Anatomy And Staying Out Of Trouble In Acute Stroke |
Presenters(s):Jeffrey Farkas, MD | |
3:19 PM - 3:29 PM | Stroke Reimbursement: Is It Worth It? |
Presenters(s):Jeffrey Stone, MD | |
3:30 PM - 3:40 PM | Stroke And tPA: The Legal Battles! |
Presenters(s):Michael I. Weintraub, MD | |
3:41 PM - 4:00 PM | Discussion |
END OF SESSION 10 | |
Thursday, November 18, 2010
Print Entire 2010 Program:
|
|
SESSION 11 SCHEDULE | |
Thursday
SESSION 11:
NEW DEVELOPMENTS IN ENDOVASCULAR HEART VALVES AND APPROACHES TO TREAT THORACIC AORTIC LESIONS (5-MINUTE TALKS)
Moderators:Roy K. Greenberg, MD / Lars G. Svensson, MD, PhD
|
|
x | |
6:35 AM - 6:40 AM | Opening Remarks |
Presenters(s):Frank J. Veith, MD | |
6:40 AM - 6:45 AM | Direct Minimally Invasive Videoscopic Approach To The Thoracic Aorta For Delivery Of Aortic Endografts |
Presenters(s):Willem Wisselink, MD | |
6:46 AM - 6:51 AM | A New Embolic (Brain) Protection Device During Endovascular Aortic Arch And Valve Procedures To Prevent Strokes By Covering Orifices Of Supra-aortic Trunk |
Presenters(s):Jeffrey P. Carpenter, MD | |
6:52 AM - 6:57 AM | Venous Trans-Septal Access To The Aorta And Its Branches: How Is It Done And When Can It Be Helpful? |
Presenters(s):Tilo Kölbel, MD, PhD | |
6:58 AM - 7:03 AM | Future Of Transcatheter Valves: What Will Be Left For Classical Operations: A Surgeon’s View |
Presenters(s):Todd M. Dewey, MD / Michael J. Mack, MD | |
7:04 AM - 7:09 AM | Status Of Transcatheter Aortic Valve Repair: What Will Be Left For Classical Operations? A Cardiologist’s View |
Presenters(s):Horst Sievert, MD | |
7:10 AM - 7:15 AM | Status Of Percutaneous Mitral Valve Repair: Have There Been Improvements In Devices And Techniques? |
Presenters(s):Ted Feldman, MD | |
7:16 AM - 7:21 AM | Intra-Thoracic Debranching Can Simplify The Approach To Type II Thoracoabdominal Aortic Aneurysms (TAAAs) |
Presenters(s):Patrice F. Bergeron, MD | |
7:22 AM - 7:27 AM | Treatment Of Extensive Arch And Thoracic Aneurysms With Staged Open And Endograft Techniques Using The Evita Endograft: Revascularization Of Aortic Branches |
Presenters(s):Piotr M. Kasprzak, MD | |
7:28 AM - 7:33 AM | Overcoming The Challenge Of Thoracic Endograft Compression: Is Increased Radial Force The Answer? |
Presenters(s):Dittmar Boeckler, MD | |
7:34 AM - 7:44 AM | Panel Discussion |
TOPICS PRESENTED BY TITLE: (SYNCHRONIZED TALKS, SLIDES AND ABSTRACTS THAT WILL BE AVAILABLE ON OUR WEB-BASED VERSION 5 WEEKS AFTER THE MEETING.) | |
Web-Based Presentation | 11.1 - Laparoscopically Assisted TEVAR Via The Aorta Or Common Iliac Artery When Femoral And External Iliac Access Is Impossible |
Presenters(s):Ralf R. Kolvenbach, MD | |
Web-Based Presentation | 11.2 - Primary And Secondary Aorto-Esophageal And Aortobronchial Fistulas And Their Modern Treatment |
Presenters(s):Roberto Chiesa, MD | |
Web-Based Presentation | 11.3 - Comparative Analysis Of Open And Endovascular Repair Of Ruptured Descending Thoracic Aortic Aneurysms (RTAAs) |
Presenters(s):Gilbert R. Upchurch, MD | |
Web-Based Presentation | 11.4 - Neurological Complications Of TEVAR And Their Management: Paraplegia Is Reversible Whereas Stroke Is Not |
Presenters(s):Peter R. Taylor, MA, MChir, FRCS | |
Web-Based Presentation | 11.5 - Is Spinal Ischemia With TEVAR More Of A Problem When Patients Have A Previous AAA Repair? |
Presenters(s):Carlo Setacci, MD | |
END OF SESSION 11 | |
SESSION 12 SCHEDULE | |
Thursday
SESSION 12:
NEW DEVELOPMENTS IN TREATMENT OF THORACIC AND THORACOABDOMINAL AORTIC DISEASE (5-MINUTE TALKS)
Moderators:Edward B. Diethrich, MD / Peter R. Taylor, MA, MChir, FRCS
|
|
x | |
7:45 AM - 7:50 AM | Simplified Arch Aneurysm Treatment With Fenestrated Endografts: How Can It Work And Initial Experience |
Presenters(s):Yoshihiko Yokoi, MD / Hiroshi Shigematsu, MD, PhD | |
7:51 AM - 7:56 AM | Debate 1: New Developments In Branched And Fenestrated Endografts Suggest There Will Be No Role For Open Surgery In Repair Of TAAAs |
Presenters(s):Stephan Haulon, MD | |
7:57 AM - 8:02 AM | Debate 1: There Will Always Be A Role For Open Surgical Repair Of TAAAs Even With Improved Endografts |
Presenters(s):Michael J. Jacobs, MD | |
8:03 AM - 8:08 AM | Open And Endovascular Repair Of Descending Thoracic Aortic Aneurysms: There Is A Role For Both: What Is It? |
Presenters(s):Roberto Chiesa, MD | |
8:09 AM - 8:14 AM | Exclusion Of Ascending Aorta And Aortic Arch Aneurysms Is Now Feasible By A Totally Endovascular Approach |
Presenters(s):Ralf R. Kolvenbach, MD | |
8:15 AM - 8:20 AM | Experience With A New Simplified Device To Treat Aortic Arch Aneurysms With Branched Endografts And Other Possible Future Designs |
Presenters(s):Krassi Ivancev, MD, PhD / David E. Hartley, FRANZCR (Hon) | |
8:21 AM - 8:26 AM | Advances In In Situ Fenestration For Total Endovascular Arch Repair To Improve Branch Stability And Maintain Brain Perfusion During The Procedure |
Presenters(s):Bjõrn Sonesson, MD, PhD | |
8:27 AM - 8:32 AM | Debate 2: Properly Constructed Chimney Or Snorkel Grafts Can Work To Revascularize Aortic Arch Branches |
Presenters(s):Armando C. Lobato, MD, PhD | |
8:33 AM - 8:38 AM | Debate 2: Mechanical Stress And Strains On Branches In The Aortic Arch Mean Chimney Grafts Won’t Work Well Here |
Presenters(s):Jacques Bleyn, MD | |
8:39 AM - 8:48 AM | Panel Discussion |
TOPICS PRESENTED BY TITLE: (SYNCHRONIZED TALKS, SLIDES AND ABSTRACTS THAT WILL BE AVAILABLE ON OUR WEB-BASED VERSION 5 WEEKS AFTER THE MEETING.) | |
Web-Based Presentation | 12.1 - A Novel More Effective Glue-Sealant (ArterX) For Hemostasis At Vascular Suture Lines And Other Sites |
Presenters(s):William M. Stone, MD / Samuel R. Money, MD, MBA | |
Web-Based Presentation | 12.2 - New Hybrid Procedures For Ascending Aorta And Arch Reconstructions To Treat Difficult Aneurysms |
Presenters(s):Christoph A. Nienaber, MD, PhD | |
Web-Based Presentation | 12.3 - In Situ Retrograde Arch Fenestration Techniques Are Going To Become Standard To Repair Arch Lesions: Current Technique And Experience |
Presenters(s):Furuzan Numan, MD | |
Web-Based Presentation | 12.4 - Device Designs To Meet The Challenges Of The Aortic Arch |
Presenters(s):Wei Guo, MD | |
END OF SESSION 12 | |
SESSION 13 SCHEDULE | |
Thursday
SESSION 13:
NEW DEVELOPMENTS IN STENT-GRAFTS, STENTS AND TECHNIQUES FOR TREATING THORACIC AORTIC LESIONS: MORE ABOUT COMPLICATIONS AND PATHOLOGY (5-MINUTE TALKS)
Moderators:Krassi Ivancev, MD, PhD / Nicholas J.W. Cheshire, MD
|
|
x | |
8:49 AM - 8:54 AM | Pathogenesis, Prevention And Treatment Of Retrograde Type A Dissection After TEVAR And Open Surgery |
Presenters(s):Rodney A. White, MD | |
8:55 AM - 9:00 AM | Perspective On The Causes, Prevention And Treatment Of Type A Dissections As A Complication Of TEVAR For Type B Dissections |
Presenters(s):Burkhart Zipfel, MD | |
9:01 AM - 9:06 AM | Endograft Treatment Of Type A Dissection: Real And Theoretical Systems Will Make This Feasible |
Presenters(s):Christoph A. Nienaber, MD, PhD | |
9:07 AM - 9:12 AM | Dynamic MR In Type B Dissections: Value In Determining Flap Mobility And Organ Perfusion; And In Guiding Treatment |
Presenters(s):Alan B. Lumsden, MD, FACS | |
9:13 AM - 9:18 AM | Indications, Techniques And Outcomes After Endovascular Treatment Of Chronic Type B Aortic Dissections In Patients With And Without Marfan’s Syndrome |
Presenters(s):Geoffrey H. White, MD | |
9:19 AM - 9:24 AM | Techniques For Endograft Treatment Of Dissecting Aortic Aneurysms Involving All Or Part Of The Arch: The "Miracle Technique" For Revascularization Of Arch Branches |
Presenters(s):Zaiping Jing, MD | |
9:25 AM - 9:30 AM | Update On The STABLE Trial With A Proximal Endograft And A Distal Uncovered Stent |
Presenters(s):Joseph V. Lombardi, MD | |
9:31 AM - 9:36 AM | Improving Distal Fixation And Sealing In Thoracic Endografting With A Distal Graft Scallop For Visceral Arteries: Precautions And Results |
Presenters(s):Vicente Riambau, MD, PhD | |
9:37 AM - 9:42 AM | Strategies For Complex Hybrid Aortic Endografting |
Presenters(s):Edward B. Diethrich, MD | |
9:43 AM - 9:48 AM | Technique For Rapid Pacing And How It Helps In The Better Deployment Of Thoracic Endografts |
Presenters(s):Dietmar H. Koschyk, MD | |
9:49 AM - 9:55 AM | Panel Discussion |
9:50 AM - 10:05 AM | Break / Visit Exhibits and Pavilions (2nd and 3rd Floors) |
TOPICS PRESENTED BY TITLE: (SYNCHRONIZED TALKS, SLIDES AND ABSTRACTS THAT WILL BE AVAILABLE ON OUR WEB-BASED VERSION 5 WEEKS AFTER THE MEETING.) | |
Web-Based Presentation | 13.1 - Lessons Learned In 460 TEVARs: Mistakes That Can Be Avoided |
Presenters(s):W. Anthony Lee, MD | |
Web-Based Presentation | 13.2 - More Extensive Aortic Coverage By TEVAR In Type B Dissections Produces Better Outcomes |
Presenters(s):Matt M. Thompson, MD | |
Web-Based Presentation | 13.3 - Endovascular Methods Other Than Endografts For Treating Thoracic Aortic Aneurysms |
Presenters(s):James May, MD, MS, FRACS, FACS | |
Web-Based Presentation | 13.4 - Early Clinical Experience With Endovascular Treatment Of Type A Dissecting Aneurysms |
Presenters(s):Matt M. Thompson, MD | |
Web-Based Presentation | 13.5 - Debate: Endovascular Treatment Of Uncomplicated Type B Aortic Dissection Is Beneficial |
Presenters(s):Rodney A. White, MD | |
Web-Based Presentation | 13.6 - Debate: Endovascular Treatment Of Uncomplicated Type B Aortic Dissection Is Not Beneficial |
Presenters(s):Jan S. Brunkwall, MD, PhD | |
Web-Based Presentation | 13.7 - Lessons Learned From Pathologic Exam After TEVAR Failure |
Presenters(s):Alan B. Lumsden, MD, FACS | |
END OF SESSION 13 | |
SESSION 14 SCHEDULE | |
Thursday
SESSION 14:
LOWER EXTREMITY ENDOVASCULAR HOT TOPICS - PART 1 (5-MINUTE TALKS)
Moderators:Enrico Ascher, MD / Alan M. Graham, MD
|
|
x | |
6:40 AM - 6:45 AM | Opening Remarks |
Presenters(s):Frank J. Veith, MD | |
6:45 AM - 6:50 AM | Results With Jetstream Atherectomy/Thrombectomy In Infrainguinal Arterial Disease: What Makes It Different From Other Devices? |
Presenters(s):Venkatesh G. Ramaiah, MD | |
6:51 AM - 6:56 AM | Importance Of Embolization During Lower Extremity Endovascular Procedures: How Can It Be Prevented And Treated? |
Presenters(s):Nicholas J. Morrissey, MD | |
6:57 AM - 7:02 AM | The ANGIOSLIDE Balloon Catheter To Capture Embolic Material Released During Lower Extremity Angioplasty: A New Concept In Distal Embolic Protection |
Presenters(s):Gunnar Tepe, MD | |
7:03 AM - 7:08 AM | Multicenter Belgian-Italian Trial Evaluating The Long-Term (Up To 24 Months) Outcome Of The Self-Expanding Nitinol Absolute Pro And The Balloon-Expandable Omnilink Elite Stent In TASC A & B And TASC C & D Iliac Lesions In 325 Patients |
Presenters(s):Patrick Peeters, MD | |
7:09 AM - 7:14 AM | Debate 3: Atherectomy Really Works Better Than POBA: Why Can’t Others Reproduce The Good Results? |
Presenters(s):James F. McKinsey, MD | |
7:15 AM - 7:20 AM | Debate 3: Atherectomy Really Does Not Work Very Well Even Though I Tried It |
Presenters(s):Julio A. Rodriguez-Lopez, MD | |
7:21 AM - 7:26 AM | Tips, Tricks, Techniques And Indications In Pedal Artery Access |
Presenters(s):Craig M. Walker, MD | |
7:27 AM - 7:32 AM | Can Diabetics With Neuropathy Have Their Symptoms Relieved By PTA: Do The Symptoms Recur With Restenosis? |
Presenters(s):Alan E. Bray, MD, FRACS | |
7:33 AM - 7:39 AM | Panel Discussion |
TOPICS PRESENTED BY TITLE: (SYNCHRONIZED TALKS, SLIDES AND ABSTRACTS THAT WILL BE AVAILABLE ON OUR WEB-BASED VERSION 5 WEEKS AFTER THE MEETING.) | |
Web-Based Presentation | 14.1 - How Do We Know Atherectomy Works? |
Presenters(s):Gary M. Ansel, MD | |
Web-Based Presentation | 14.2 - Value Of Drug Eluting Balloons In Below The Knee Artery PTAs |
Presenters(s):Marco G. Manzi, MD | |
Web-Based Presentation | 14.3 - Tips And Tricks And New Techniques For Crossing Difficult SFA And Popliteal Occlusions: Is The Radiofrequency Wire Going To Help And How Can It Be Used? |
Presenters(s):Andrej Schmidt, MD, PhD | |
Web-Based Presentation | 14.4 - Use Of Standardized Percutaneous Techniques For SFA And Popliteal Artery TASC C And D Lesions Improves Outcomes |
Presenters(s):Manish Mehta, MD, MPH | |
END OF SESSION 14 | |
SESSION 15 SCHEDULE | |
Thursday
SESSION 15:
LOWER EXTREMITY HOT TOPICS II (5-MINUTE TALKS)
Moderators:Kenneth Ouriel, MD, FACS, FACC / Gary Giangola, MD
|
|
x | |
7:40 AM - 7:45 AM | Why We Should Still Perform Pedal Bypasses In Some Patients |
Presenters(s):Werner Lang, MD | |
7:46 AM - 7:51 AM | Mid-Term Experience With Drug Eluting Balloons In SFA And Popliteal Arteries |
Presenters(s):Giancarlo Biamino, MD, PhD | |
7:52 AM - 7:57 AM | Debate 4: Stent Fractures In The SFA Do Matter: Let’s Look At The Data |
Presenters(s):Dierk Scheinert, MD | |
7:58 AM - 8:03 AM | Debate 4: Stent Fractures In The SFA Do Not Really Matter |
Presenters(s):Erich Minar, MD | |
8:04 AM - 8:09 AM | How Does Paclitaxil On Stents And Balloons Work To Prevent Restenosis? |
Presenters(s):Alberto Cremonesi, MD, FESC | |
8:10 AM - 8:15 AM | Drug-Eluting Stents Below The Knee - Promises And Limitations: Update On The DESTINY And ACHILLES Trials Comparing DE To Bare Metal Stents |
Presenters(s):Marc Bosiers, MD | |
8:16 AM - 8:21 AM | What Is The eXtra Balloon And What Is Its Value In Endovascular Interventions? |
Presenters(s):Gary M. Ansel, MD | |
8:22 AM - 8:27 AM | Debunking Another Surgical Myth: Stenting The CFA Is Always Bad And Must Be Avoided |
Presenters(s):Frank J. Criado, MD, FACS, FSVM | |
8:28 AM - 8:33 AM | Value Of Drug Eluting (Cypher) Stents For Critical Limb Ischemia (CLI) After Failed PTA: Favorable Mid-Term Patency And Limb Salvage Results |
Presenters(s):Robert A. Lookstein, MD, FSIR, FAHA | |
8:33 AM - 8:40 AM | Panel Discussion |
TOPICS PRESENTED BY TITLE: (SYNCHRONIZED TALKS, SLIDES AND ABSTRACTS THAT WILL BE AVAILABLE ON OUR WEB-BASED VERSION 5 WEEKS AFTER THE MEETING.) | |
Web-Based Presentation | 15.1 - SFA And Crural Endovascular Revascularization: How Does One Decide Which Method To Use? |
Presenters(s):Peter A. Schneider, MD | |
Web-Based Presentation | 15.2 - Optimal Treatment For In-Stent Restenosis In The SFA; Below The Knee |
Presenters(s):Craig M. Walker, MD | |
Web-Based Presentation | 15.3 - Does Cryoplasty Still Have A Role In The Treatment Of CLI? |
Presenters(s):Bauer E. Sumpio, MD, PhD | |
END OF SESSION 15 | |
SESSION 16 SCHEDULE | |
Thursday
SESSION 16:
LOWER EXTREMITY HOT TOPICS III (5-MINUTE TALKS)
Moderators:Richard M. Green, MD / Michael F. Silane, MD
|
|
x | |
8:41 AM - 8:46 AM | Results Of A Phase 3 Trial Of Novel Targeted Angiogenic Therapy With NV1FGF For Critical Limb Ischemia |
Presenters(s):Iris Baumgartner, MD / Nicolas A. Diehm, MD | |
8:47 AM - 8:52 AM | Debate 5: Long-Term Outcomes Of PTA For CLI: Outcomes Justify A PTA First Strategy: But In Whhich Patients? |
Presenters(s):Mark Conrad, MD | |
8:53 AM - 8:58 AM | Debate 5: Failed PTA/Stent Is Associated With Reduced Patency Of Subsequent Bypass: A Study From The VSGNE Database |
Presenters(s):Jack L. Cronenwett, MD | |
8:59 AM - 9:04 AM | Retrograde Popliteal Access For SFA Recanalization: Indications, Technique And Results |
Presenters(s):Plinio Rossi, MD | |
9:05 AM - 9:10 AM | How To Do Popliteal Punctures And Procedures With The Patient In The Supine Position |
Presenters(s):Kiang Hiong Tay, MBBS, FRCR, FAMS, FSIR | |
9:11 AM - 9:16 AM | Patterns Of Recurrent Disease After SFA Interventions: How Should Such Recurrences Be Managed? |
Presenters(s):Robert Y. Rhee, MD | |
9:17 AM - 9:22 AM | Drug Eluting Balloons Improve Results Of PTA For Long Tibial Artery Lesions |
Presenters(s):Andrej Schmidt, MD, PhD | |
9:23 AM - 9:28 AM | Durability Of PTAs Using Pedal Artery Approaches |
Presenters(s):Craig M. Walker, MD | |
9:29 AM - 9:34 AM | Patient Selection For Drug Eluting Stents In The Lower Extremity |
Presenters(s):Dierk Scheinert, MD | |
9:35 AM - 9:40 AM | Below The Ankle Angioplasty: To Stent Or Not To Stent |
Presenters(s):Konstantinos Katsanos, MD | |
9:41 AM - 9:47 AM | Panel Discussion |
9:48 AM - 10:05 AM | Break / Visit Exhibits and Pavilions (2nd and 3rd Floors) |
TOPICS PRESENTED BY TITLE: (SYNCHRONIZED TALKS, SLIDES AND ABSTRACTS THAT WILL BE AVAILABLE ON OUR WEB-BASED VERSION 5 WEEKS AFTER THE MEETING.) | |
Web-Based Presentation | 16.1 - How To Avoid Use Of Reentry Devices When Crossing Total Occlusions |
Presenters(s):Ali Amin, MD, RVT, FACS, FACC | |
Web-Based Presentation | 16.2 - Debate: Tibial Artery Lesions With CLI Do Better With Distal Open Bypasses |
Presenters(s):Hans-Henning Eckstein, MD, PhD | |
Web-Based Presentation | 16.3 - Debate: Tibial Artery Lesions With CLI Do Better With Endovascular Treatment |
Presenters(s):Iris Baumgartner, MD | |
Web-Based Presentation | 16.4 - Long Bare Nitinol Stents For TASC C And D Fem-Pop Lesions (The DURABILIITY Trial): How Well Do They Do? |
Presenters(s):Marc Bosiers, MD | |
Web-Based Presentation | 16.5 - Techniques And Advantages Of Treating Lower Extremity Disease With 4 French Systems: What Is Possible And What Is Not? |
Presenters(s):Andrej Schmidt, MD, PhD | |
END OF SESSION 16 | |
SESSION 17 SCHEDULE | |
Thursday
SESSION 17:
NEW DEVELOPMENTS IN SFA AND CRURAL ARTERY TREATMENTS AND MANAGEMENT OF CLI (5-MINUTE TALKS)
Moderators:Dennis F. Bandyk, MD / Michael B. Silva, Jr., MD
|
|
x | |
10:05 AM - 10:10 AM | Performance Goals And Clinical Trial Designs To Permit Rapid Accurate Evaluation Of Safety And Efficacy Of CLI Treatment Devices |
Presenters(s):Michael S. Conte, MD | |
10:11 AM - 10:16 AM | Are We Making Progress In The Endovascular Treatment Of SFA Disease Or Will All Treatments Prove Equally Ineffective: Is The High Cost Worth The Price? |
Presenters(s):Kenneth Rosenfield, MD | |
10:17 AM - 10:22 AM | Endo First vs. Open First For CLI: Is The BASIL Trial Applicable In 2010: Is It Still Helpful? |
Presenters(s):Andrew W. Bradbury, MD, FRCSEd | |
10:23 AM - 10:28 AM | Long-Term Outcomes Of Endovascular Infrainguinal Treatments: Are They A Viable Modality Or A Revenue Generator? |
Presenters(s):Clifford J. Buckley, MD | |
10:29 AM - 10:34 AM | Late Results (3-5 Years) After Endovascular Treatment Of Crural And Pedal Disease Causing CLI |
Presenters(s):Roberto Ferraresi, MD | |
10:35 AM - 10:40 AM | Endovascular Techniques For Limb Salvage In Diabetics With Crural And Pedal Disease – Including Pedal Loop Techniques |
Presenters(s):Marco G. Manzi, MD | |
10:41 AM - 10:46 AM | Early And Mid-Term Results Of Transpedal Revascularization Procedures |
Presenters(s):Andrej Schmidt, MD, PhD | |
10:47 AM - 10:52 AM | Tricks For Crossing Total Occlusions In Lower Extremity Arteries |
Presenters(s):Tony S. Das, MD | |
10:53 AM - 10:59 AM | Panel Discussion |
Moderator(s): Kenneth Ouriel, MD, FACS, FACC / George H. Meier III, MD | |
11:00 AM - 11:05 AM | Results Of Randomized Controlled Trial (RCT) Comparing Drug Eluting Stent (Zilver PTX) With PTA And Bare Metal Stent For SFA And Popliteal Lesions |
Presenters(s):Michael D. Dake, MD | |
11:06 AM - 11:11 AM | Results Of RCT Comparing Paclitaxil Coated Balloons With Uncoated Balloons For PTA In The SFA And Proximal Popliteal Artery (PACURA I Trial) |
Presenters(s):Johannes Lammer, MD | |
11:12 AM - 11:17 AM | Tips And Tricks For Treating Lower Extremity Occlusions In The SFA, Popliteal And Tibial Arteries: Can They All Be Crossed And How? |
Presenters(s):Thomas Zeller, MD | |
11:18 AM - 11:23 AM | Treatment Of In-Stent Restenosis: Is There Anything That Works? |
Presenters(s):John R. Laird, MD | |
11:24 AM - 11:29 AM | An Overview Of Drug Eluting Balloons: So Many Companies: So Many Trials: Where Are We And Where Are We Going? |
Presenters(s):Gunnar Tepe, MD | |
11:30 AM - 11:35 AM | Subintimal Recanalization Of Occluded Stents: The “Substent Technique” |
Presenters(s):Konstantinos Katsanos, MD | |
11:36 AM - 11:41 AM | Value Of Stem Cells From Bone Marrow In Otherwise Untreatable Patients With CLI Facing Amputation: It Works |
Presenters(s):Ralf R. Kolvenbach, MD | |
11:42 AM - 11:47 AM | Heparin Bonded PTFE vs. Vein In Below-Knee Bypasses: The U.S. And European Experience |
Presenters(s):Richard F. Neville, MD | |
11:48 AM - 11:55 AM | Panel Discussion |
11:55 AM - 1:00 PM | Lunch Break – Visit Exhibits and Pavilions (2nd and 3rd Floors) |
Web-Based Presentation | 17.1 - Comparison Of Endovascular-First vs. Surgical Revascularization-First For Limb Salvage In CLI: 5-Year Results Are Similar |
Presenters(s):Mauri J.A. Lepantalo, MD | |
Web-Based Presentation | 17.2 - Role And Value Of The SUPERA Hi Radial Force Stent In Treating Calcified And Resistant SFA Lesions |
Presenters(s):Dierk Scheinert, MD | |
Web-Based Presentation | 17.3 - Value Of The ROTAREX System For In-Stent Restenosis At The Level Of The Iliac And Femoro-Popliteal Arteries |
Presenters(s):Gioacchino Coppi, MD | |
Web-Based Presentation | 17.4 - What Is The Best Technique And Device For Mechanical Thrombectomy With Lower Extremity Arterial Lesions? |
Presenters(s):Andrej Schmidt, MD, PhD | |
END OF SESSION 17 | |
SESSION 18 SCHEDULE | |
Thursday
SESSION 18:
NEW DEVELOPMENTS IN TEVAR AND EVAR (5-MINUTE TALKS)
Moderators:Rajiv Parakh, MBBS, MS, FRCS / Frank J. Veith, MD
|
|
x | |
1:00 PM - 1:05 PM | Preserving Spinal Cord Vascularization With TEVAR: From Theory To Practice |
Presenters(s):Germano Melissano, MD | |
1:06 PM - 1:11 PM | Advantages Of The Cook PROFORM Thoracic Graft: Initial Clinical Experience |
Presenters(s):Timothy A. Resch, MD, PhD | |
1:12 PM - 1:17 PM | An Improved Thoracic Endograft For Tight Radius Aortic Arches: Advantages And Initial Clinical Experience |
Presenters(s):Peter R. Taylor, MA, MChir, FRCS | |
1:18 PM - 1:23 PM | New Developments In Thoracic Endografting And What Is On The Horizon |
Presenters(s):Michael D. Dake, MD | |
1:24 PM - 1:29 PM | Use Of Vascular Occluding Devices For Treating Reentry Tears In Patients With Persistent False Lumens After Endograft Treatment Of Type B Aortic Dissections |
Presenters(s):Wei Guo Fu, MD | |
1:30 PM - 1:35 PM | Debate 6: TAAAs Will All Be Treated With Endovascular Techniques |
Presenters(s):Peter L. Harris, MD, FRCS | |
1:36 PM - 1:41 PM | Debate 6: That’s Nonsense: Some TAAAs Are And Will Always Best Be Treated By Open Repair |
Presenters(s):Hazim J. Safi, MD | |
1:42 PM - 1:47 PM | Panel Discussion |
Moderator(s): Robert B. Rutherford, MD / Mario Lachat, MD | |
1:47 PM - 1:52 PM | Debate 7: We Still Need A Randomized Controlled Trial (RCT) Of EVAR vs. Open Repair (OR) For Ruptured AAAs: The Ongoing (AJAX And ECAR) Trials Prove It |
Presenters(s):Willem Wisselink, MD / Jean-Pierre Becquemin, MD, FRCS / Marc R.H. van Sambeek, MD, PhD | |
1:53 PM - 1:58 PM | Debate 7: RCTs Of EVAR And OR In Ruptured AAAs Are A Waste Of Time And Will Provide No Useful Information |
Presenters(s):Dieter O. Mayer, MD | |
1:59 PM - 2:04 PM | EVAR And OR For Ruptured AAA Produce Equal Mortality Rates: Other Factors Like Organization And Fluid Management Are More Important Than The Method Of Repair |
Presenters(s):Jürg Schmidli, MD | |
2:05 PM - 2:10 PM | “EVAR Suitable Anatomy” Is A Favorable Factor For Open Repair Of Ruptured AAAs And Results In Better Outcomes: Maybe We Do Need A RCT But It Will Be Impossible To Carry Out |
Presenters(s):Florian Dick, MD | |
2:11 PM - 2:16 PM | Do Endoleaks After EVAR For RAAA Matter: How Should They Be Dealt With? |
Presenters(s):Benjamin W. Starnes, MD | |
2:17 PM - 2:22 PM | Panel Discussion |
TOPICS PRESENTED BY TITLE: (SYNCHRONIZED TALKS, SLIDES AND ABSTRACTS THAT WILL BE AVAILABLE ON OUR WEB-BASED VERSION 5 WEEKS AFTER THE MEETING.) | |
Web-Based Presentation | 18.1 - Management Of Spinal Ischemia After Endovascular Repair Of TAAs Or TAAAs |
Presenters(s):Timothy A.M. Chuter, DM | |
Web-Based Presentation | 18.2 - Prevention Of Spinal Cord Complications With TEVAR |
Presenters(s):John E. Connolly, MD | |
Web-Based Presentation | 18.3 - Resolving The Continuing Confusion Over Acute And Chronic Type B Aortic Dissections: Why Is The Distinction Crucial: An Endovascular Therapist’s Perspective |
Presenters(s):Frank J. Criado, MD, FACS, FSVM | |
Web-Based Presentation | 18.4 - TEVAR And Covering The Celiac Artery: Is It Safe Or Not? |
Presenters(s):Lars Lonn, MD, PhD | |
END OF SESSION 18 | |
SESSION 19 SCHEDULE | |
Thursday
SESSION 19:
CRITICAL EVALUATION OF CAROTID ARTERY STENTING (CAS) IN NOVEMBER 2010 (5-MINUTE TALKS)
Moderators:Thomas S. Riles, MD / Anne L. Abbott, MD, PhD, FRACP
|
|
x | |
2:22 PM - 2:27 PM | Ten Top Tips For SAFE CAS: A Neuroradiologist’s Perspective |
Presenters(s):Emmanuel M. Houdart, MD | |
2:28 PM - 2:33 PM | Debate 8: CREST Has Restored CAS To Its Rightful Place As Best Treatment For Most Carotid Stenoses: An Interventionalist’s Perspective |
Presenters(s):William A. Gray, MD | |
2:34 PM - 2:39 PM | Debate 8: CREST May Be Helpful To Advocates Of CAS But It Is Not The Final Answer: When CEA, When CAS, When Best Medical Treatment (BMRx): A Surgeon’s Perspective |
Presenters(s):Wesley S. Moore, MD | |
2:40 PM - 2:45 PM | Debate 8: Subanalysis Of CREST Results Are Important: Were There Differences Between CAS And CEA In 1) Quality Of Life And 2) Cost Effectiveness; What Were The Severity And Disability From The MIs And The Cranial Nerve Injuries: A Neurologist’s Perspective |
Presenters(s):Thomas G. Brott, MD | |
2:46 PM - 2:51 PM | The Woes Of CAS Are Not Fully Solved By CREST: When Is CAS Justified And When And Why Is It Not? |
Presenters(s):Frank J. Criado, MD, FACS, FSVM | |
2:52 PM - 2:57 PM | Debate 9: We Do Not Need Any More CAS Trials After CREST And ICSS |
Presenters(s):Mark H. Wholey, MD | |
2:58 PM - 3:03 PM | Debate 9: We Need Additional CAS Trials And Why |
Presenters(s):Andrew N. Nicolaides, MS, FRCS | |
3:04 PM - 3:09 PM | Debate 10: Asymptomatic Carotid Stenosis Is Still An Indication For Treatment By CEA Or CAS In Most Patients Needing Aggressive Treatment (CABG Or PCI) For Coronary Artery Disease |
Presenters(s):John (Jeb) W. Hallett, MD | |
3:10 PM - 3:15 PM | Debate 10: Asymptomatic Carotid Stenosis Is Still An Indication For CEA Or CAS, In Some Patients Needing Aggressive Treatment (CABG Or PCI) For Coronary Artery Disease |
Presenters(s):John J. Ricotta, MD | |
3:16 PM - 3:21 PM | Debate 10: Most Patients Undergoing Cardiac Surgery With Asymptomatic Carotid Disease Do Not Benefit From A Synchronous Or Staged Carotid Intervention |
Presenters(s):A. Ross Naylor, MD, FRCS | |
3:22 PM - 3:27 PM | Panel Discussion |
Moderator(s): Frank J. Veith, MD / Mark H. Wholey, MD | |
3:27 PM - 3:32 PM | Are There Neuropsychological Complications Of CAS Or CEA In The Absence Of Strokes? |
Presenters(s):Wei Zhou, MD | |
3:33 PM - 3:38 PM | CAS vs. CEA: What Are The DWI MRA, Brain Damage Markers And Neuropsychological Consequences Of The Two Procedures In Asymptomatic Patients: An Update |
Presenters(s):Laura Capoccia, MD | |
3:39 PM - 3:44 PM | SPACE II: The Most Needed Comparison Of CAS, CEA And BMRx For Asymptomatic Disease: Will It Provide Answers And When? |
Presenters(s):Hans-Henning Eckstein, MD, PhD | |
3:45 PM - 3:50 PM | When Is Cessation Or Reversal Of Brain Flow Protection A Must In CAS: What Are Its Disadvantages? |
Presenters(s):L. Nelson Hopkins, MD | |
3:51 PM - 3:56 PM | National Database Update On CEA vs. CAS For Symptomatic And Asymptomatic Disease: Are CAS Results Improving? |
Presenters(s):Mohammad H. Eslami, MD, RVT | |
3:57 PM - 4:02 PM | Serial Duplex Measurements Of Asymptomatic Carotid Lesions: Will They Help Identify Patients At Higher Risk For Stroke Who Will Benefit More From Invasive Treatment? |
Presenters(s):Alison Halliday, MS, FRCS | |
4:03 PM - 4:08 PM | How Can Asymptomatic Patients With Carotid Stenoses Be Identified To Be At High Stroke Risk In The Statin Era? |
Presenters(s):J. David Spence, MD | |
4:09 PM - 4:15 PM | Panel Discussion |
4:15 PM - 4:25 PM | Break – Visit Exhibits and Pavilions (2nd and 3rd Floors) |
TOPICS PRESENTED BY TITLE: (SYNCHRONIZED TALKS, SLIDES AND ABSTRACTS THAT WILL BE AVAILABLE ON OUR WEB-BASED VERSION 5 WEEKS AFTER THE MEETING.) | |
Web-Based Presentation | 19.1 - Toward Safer CAS: Tips And Tricks |
Presenters(s):Sumaira Macdonald, MBChB (Comm), FRCP, FRCR, PhD | |
Web-Based Presentation | 19.2 - Does The CRYSTALLO Variable Cell Size Stent Lower Embolic Event Rates With CAS? |
Presenters(s):Alberto Cremonesi, MD, FESC | |
Web-Based Presentation | 19.3 - Right Brachial Approach For Left Carotid Stenting With A Bovine Arch Anatomy |
Presenters(s):Patrick E. Muck, MD, RVT, FACS | |
Web-Based Presentation | 19.4 - Radial Approach For CAS: When, Why And How |
Presenters(s):Ali Amin, MD, RVT, FACS, FACC | |
Web-Based Presentation | 19.5 - Flaws In The Empire Trial |
Presenters(s):Michael H. Wholey, MD, MBA | |
Web-Based Presentation | 19.6 - Will The TACIT Trial Ever Be Done? |
Presenters(s):Barry T. Katzen, MD | |
END OF SESSION 19 | |
SESSION 20 SCHEDULE | |
Thursday
SESSION 20:
NEW DEVELOPMENTS IN LOWER EXTREMITY STENT-GRAFTS AND STENTS (5-MINUTE TALKS)
Moderators:Mark A. Adelman, MD / Timur P. Sarac, MD
|
|
x | |
4:25 PM - 4:30 PM | Update On The VIBRANT And VIPER Trials Showing The Value Of Endoluminal Bypass With The Viabahn Stent-Graft For Long SFA Disease |
Presenters(s):Gary M. Ansel, MD | |
4:31 PM - 4:36 PM | RCT Of Viabahn Stent Grafts With Heparin Bonding vs. Bare Nitinol Stents In SFA Disease (The VIASTAR Trial): The Importance Of Edge Stenosis |
Presenters(s):Johannes Lammer, MD | |
4:37 PM - 4:42 PM | Endovascular Stent-Graft Treatment Of Popliteal Aneurysms With Only Duplex Guidance |
Presenters(s):Enrico Ascher, MD | |
4:43 PM - 4:48 PM | Are Stent-Grafts Better Than Bare Metal Stents For Treating Iliac Artery Occlusions (The COBEST Trial): What Is Their History And Limitations? |
Presenters(s):Patrice B. Mwipatayi, FRACS | |
4:49 PM - 4:54 PM | Results With Second Generation Tissue Covered Stent-Grafts In The SFA And Popliteal Arteries |
Presenters(s):Albrecht H. Krämer, MD / Timur P. Sarac, MD / Francisco Valdes, MD | |
4:55 PM - 5:00 PM | What Is The Future For Biodegradable Stents And Biodegradable Polymers? |
Presenters(s):Ron Waksman, MD | |
5:01 PM - 5:06 PM | Evolving Experience With Intracranial Stents: The Good And The Bad |
Presenters(s):L. Nelson Hopkins, MD | |
5:07 PM - 5:12 PM | Panel Discussion |
TOPICS PRESENTED BY TITLE: (SYNCHRONIZED TALKS, SLIDES AND ABSTRACTS THAT WILL BE AVAILABLE ON OUR WEB-BASED VERSION 5 WEEKS AFTER THE MEETING.) | |
Web-Based Presentation | 20.1 - Debate: Open Surgery Is Still The Primary Approach For CLI |
Presenters(s):R. Clement Darling III, MD | |
Web-Based Presentation | 20.2 - Debate: Endovascular Treatments Should Be The Primary Approach For CLI: But Not For All Patients |
Presenters(s):Ali Amin, MD, RVT, FACS, FACC | |
Web-Based Presentation | 20.3 - Are Failed Stent-Grafts In The SFA More Likely To Lead To CLI Than Failed Stents Or POBA? |
Presenters(s):Gary M. Ansel, MD | |
Web-Based Presentation | 20.4 - How Can Computer Modeling Help To Design Better Stents For Treating Fempop Occlusive Disease? |
Presenters(s):Jörn O. Balzer, MD, PhD | |
Web-Based Presentation | 20.5 - Nitinol Stents Can Be Effective Across The Knee Joint |
Presenters(s):Luis R. Leon, MD, RVT, FACS | |
END OF SESSION 20 | |
SESSION 21 SCHEDULE | |
Thursday
SESSION 21:
NEW CONCEPTS IN VASCULAR DISEASE AND ITS TREATMENT (4 AND 5-MINUTE TALKS)
Moderators:James F. McKinsey, MD / Frank J. Veith, MD
|
|
x | |
5:12 PM - 5:17 PM | Overview Of Established And New Antiplatelet Agents |
Presenters(s):Gregg W. Stone, MD | |
5:18 PM - 5:23 PM | Treatment Of Multiple Sclerosis By Interventional Procedures To Reduce Venous Obstruction: When Is It Helpful And When Is It Not? |
Presenters(s):Paolo Zamboni, MD | |
5:24 PM - 5:29 PM | Radiofrequency Periarterial Nerve Ablation From Within The Renal Artery To Treat Resistant Hypertension: Does It Work And How? |
Presenters(s):Dierk Scheinert, MD | |
5:30 PM - 5:35 PM | Importance Of Previously Undetected Arrhythmias In High Risk Vascular Surgery Patients: The REVEAL Monitoring Device And How It Can Help Patient Management |
Presenters(s):Hence J.M. Verhagen, MD, PhD | |
5:36 PM - 5:41 PM | Difficult A-V Malformations Can Be Treated Effectively But It Is Hard: Tips And Tricks |
Presenters(s):Furuzan Numan, MD | |
5:42 PM - 5:47 PM | How To Start An A-V Malformation Program: Absolute Ethanol Can Be Dangerous But Helpful |
Presenters(s):Iris Baumgartner, MD | |
5:48 PM - 5:52 PM | A Simple Way To Understand And Treat Vascular Malformations |
Presenters(s):Peter Gaines, MD | |
5:53 PM - 5:58 PM | Treatment Of Angiodysplasia: Dirty Laundry And Lessons Learned |
Presenters(s):Byung-Boong Lee, MD | |
5:59 PM - 6:04 PM | Update On Stem Cell Therapy For CLI And Heart Failure: Will It Work? |
Presenters(s):Alan Dardik, MD, PhD | |
6:05 PM - 6:10 PM | Update On The Status Of Gene Therapy For CLI: Will It Work? |
Presenters(s):Richard J. Powell, MD | |
6:11 PM - 6:16 PM | Panel Discussion |
Web-Based Presentation | 21.1 - Are Stem Cells Going To Become Widely Used For CLI? |
Presenters(s):Iris Baumgartner, MD | |
END OF SESSION 21 | |
SESSION 22 SCHEDULE | |
Thursday
SESSION 22:
PREVENTION AND TREATMENT OF COMPLICATIONS (5-MINUTE TALKS)
Moderators:Barry T. Katzen, MD / Kumud Rai, MD
|
|
x | |
6:16 PM - 6:21 PM | Systemic Inflammatory Response Syndrome (SIRS) And Its Importance In Vascular And Endovascular Procedures: What Is It And How Should It Be Diagnosed And Treated? |
Presenters(s):Torben V. Schroeder, MD, DMSc / Lars Lonn, MD, PhD | |
6:22 PM - 6:27 PM | What Is The Best Way To Minimize Brain Damage During CAS: Reversal Of Flow vs. Filter vs. No EPD: A Comparative Study Using DWI And Brain Enzymes As End Points |
Presenters(s):Peter Gaines, MD | |
6:28 PM - 6:33 PM | Spiral Saphenous Vein Graft Reconstruction For Aortic Graft Infection: An Alternative For The Clagett-Nevelsteen Procedure Using Femoral (Deep) Vein Grafts |
Presenters(s):Jan M.M. Heyligers, MD, PhD | |
6:34 PM - 6:39 PM | Initial Clinical Experience With A New Low Profile AAA Stent-Graft Device (INCRAFT) From Cordis |
Presenters(s):Dierk Scheinert, MD | |
6:40 PM - 6:45 PM | Debate 11: What Advances In Percutaneous Femoral Access Make It The Preferred Method For All Large Sheath Endovascular Procedures: A New Sheath To Minimize Blood Loss |
Presenters(s):Claude Mialhe, MD | |
6:46 PM - 6:51 PM | Debate 11: Tips And Tricks For Percutaneous Access For EVAR And TEVAR (Video) |
Presenters(s):Carlos H. Timaran, MD | |
6:52 PM - 6:57 PM | Debate 11: The Case Against “Preclose” Percutaneous Closure For Routine EVAR And TEVAR |
Presenters(s):Frank J. Criado, MD, FACS, FSVM | |
6:58 PM - 7:03 PM | Is Fascial Closure Equal To Or Better Than Prostar Preclose Technique After Large Sheath Insertion: A Comparative Study |
Presenters(s):Thomas Larzon, MD | |
7:04 PM - 7:15 PM | Panel Discussion |
TOPICS PRESENTED BY TITLE: (SYNCHRONIZED TALKS, SLIDES AND ABSTRACTS THAT WILL BE AVAILABLE ON OUR WEB-BASED VERSION 5 WEEKS AFTER THE MEETING.) | |
Web-Based Presentation | 22.1 - Fascial Closure (Larzon Technique) After EVAR And TEVAR Works If Done Right And Is Cheaper: Experience In 100 Cases |
Presenters(s):Timothy A. Resch, MD, PhD | |
Web-Based Presentation | 22.2 - Versatility Of The Fibrenet System For Brain Protection During CAS: Advantages And Limitations |
Presenters(s):Gary M. Ansel, MD | |
Web-Based Presentation | 22.3 - Tips And Tricks For Arterial Puncture To Avoid Complications |
Presenters(s):Jos C. van den Berg, MD, PhD | |
Web-Based Presentation | 22.4 - Importance Of Fluvostatin In Vascular Surgery Patients: Optimal Dosing And Administration |
Presenters(s):Don Poldermans, MD | |
Web-Based Presentation | 22.5 - Bivalrudin For Anticoagulation: What Is Its Value For Peripheral Interventions? |
Presenters(s):Barry T. Katzen, MD | |
END OF SESSION 22 | |
Friday, November 19, 2010
Print Entire 2010 Program:
|
|
SESSION 23 SCHEDULE | |
Friday
SESSION 23:
NEW STENT TECHNOLOGY AND IMPROVED TECHNIQUES (5-MINUTE TALKS)
Moderators:Enrico Ascher, MD / Timur P. Sarac, MD
|
|
x | |
6:40 AM - 6:45 AM | Component Bifurcated Iliac Graft For Preservation Of The Internal Iliac Artery During EVAR |
Presenters(s):William J. Quinones-Baldrich, MD | |
6:46 AM - 6:51 AM | Thin Film Nitinol Membrane Covered Stents Can Prevent Plaque Protrusion And Decrease Emboli |
Presenters(s):David Rigberg, MD | |
6:52 AM - 6:59 AM | A PTFE Mesh Covered Stent To Prevent Plaque Prolapse And Embolization |
Presenters(s):Sumaira Macdonald, MBChB (Comm), FRCP, FRCR, PhD | |
7:00 AM - 7:05 AM | Endovascular Treatment Of Critical Hand Ischemia Due To Below-The-Elbow Arterial Disease: Are Drug Eluting Balloons Helpful? |
Presenters(s):Roberto Ferraresi, MD | |
7:06 AM - 7:11 AM | A New All Purpose Guidewire Of Variable Size And Properties To Avoid Time Consuming Exchanges: How Does It Work? |
Presenters(s):Juan C. Parodi, MD / Claudio J. Schönholz, MD | |
7:12 AM - 7:17 AM | Results From The U.S. Aorfix Trial |
Presenters(s):Mark F. Fillinger, MD | |
7:18 AM - 7:23 AM | A Two Wire Technique And Special Catheter To Facilitate And Simplify CAS |
Presenters(s):Gioacchino Coppi, MD | |
7:24 AM - 7:28 AM | Panel Discussion |
TOPICS PRESENTED BY TITLE: (SYNCHRONIZED TALKS, SLIDES AND ABSTRACTS THAT WILL BE AVAILABLE ON OUR WEB-BASED VERSION 5 WEEKS AFTER THE MEETING.) | |
Web-Based Presentation | 23.1 - New 3D Navigation Tools Using Merged CT And Fluoroscopic Images To Allow Wire And Catheter Navigation Without Contrast Injection |
Presenters(s):Jos C. van den Berg, MD, PhD | |
END OF SESSION 23 | |
SESSION 24 SCHEDULE | |
Friday
SESSION 24:
JUXTARENAL, PARARENAL AND THORACOABDOMINAL AORTIC ANEURYSMS (TAAAS), CHIMNEY OR SNORKEL GRAFTS AND OTHER TECHNIQUES TO REVASCULARIZE VISCERAL ARTERIES (5-MINUTE TALKS)
Moderators:Frank J. Veith, MD / W. Anthony Lee, MD
|
|
x | |
7:28 AM - 7:33 AM | Debate 12: Open Repair For Type IV TAAA Remains The Gold Standard For Most Good Risk Patients |
Presenters(s):Richard P. Cambria, MD | |
7:34 AM - 7:39 AM | Debate 12: Endovascular Repair With Branched Grafts Will Be Best For All Patients With Type IV TAAAs |
Presenters(s):Roy K. Greenberg, MD | |
7:40 AM - 7:45 AM | Results With An Off-The-Shelf Standardized Branched Endograft Device For TAAAs: When Can It Not Be Used? |
Presenters(s):Timothy A.M. Chuter, DM | |
7:46 AM - 7:51 AM | Do We Really Need Pre-Ordered And Off-The-Shelf Devices For Juxtarenal, Pararenal And TAAAs: How Are Surgeon-Modified Standard Endografts Improving |
Presenters(s):Gustavo S. Oderich, MD / Joseph J. Ricotta II, MD | |
7:52 AM - 7:57 AM | Debate 13: New Techniques To Optimize Results With Chimney Grafts To Revascularize Aortic Branches |
Presenters(s):Martin Malina, MD, PhD | |
7:58 AM - 8:03 AM | Debate 13: Limitations Of Chimney Grafts: They Are Not As Good As Some Say |
Presenters(s):Peter L. Harris, MD, FRCS | |
8:04 AM - 8:09 AM | Sandwich Technique For Improving Results With Chimney Grafts: Technique And Use For Hypogastric And Visceral Artery Branches |
Presenters(s):Armando C. Lobato, MD, PhD | |
8:10 AM - 8:15 AM | Multivessel “Terraced” Chimney Techniques For TAAAs: Will They Replace Branched Endografts |
Presenters(s):W. Anthony Lee, MD | |
8:16 AM - 8:21 AM | Treatment Of Juxta And Pararenal AAAs With Bilateral Parallel (Chimney) Grafts, Covered Palmaz Stents And Standard Aortic Grafts: When Can These Be Used And When Can’t They Be? |
Presenters(s):Ralf R. Kolvenbach, MD | |
8:22 AM - 8:27 AM | Periscope Chimney Technique To Help With Urgent Treatment Of TAAAs: Up And Down 4-Vessel Chimney Grafts |
Presenters(s):Mario Lachat, MD | |
8:28 AM - 8:33 AM | Technique For Retroperitoneal Approach To Abdominal (4-Vessel) Debranching For TAAAs: A Better Way |
Presenters(s):David H. Deaton, MD | |
8:34 AM - 8:39 AM | New Classification System For TAAAs In The Branched Graft Era |
Presenters(s):Marcelo Ferreira, MD | |
8:40 AM - 8:45 AM | Fenestrated Grafts: When Can They Be Used And When Should They Not Be? |
Presenters(s):Eric L.G. Verhoeven, MD, PhD | |
8:46 AM - 8:53 AM | Panel Discussion |
TOPICS PRESENTED BY TITLE: (SYNCHRONIZED TALKS, SLIDES AND ABSTRACTS THAT WILL BE AVAILABLE ON OUR WEB-BASED VERSION 5 WEEKS AFTER THE MEETING.) | |
Web-Based Presentation | 24.1 - Deployment Problems With Branched And Fenestrated Endografts: Rescue Procedures From "Nightmares" |
Presenters(s):Marcelo Ferreira, MD | |
Web-Based Presentation | 24.2 - Fenestrated Grafts With Preloaded Wires: How Do They Help And Can Fenestrated And Branched Grafts Be Inserted With One Sided Access? |
Presenters(s):Krassi Ivancev, MD, PhD / David E. Hartley, FRANZCR (Hon) | |
Web-Based Presentation | 24.3 - A New Non-Sutured Telescoping Anastomotic Technique For Major Aortic Branch Revascularization With Minimal Dissection And Ischemia |
Presenters(s):Zoran Rancic, MD, PhD / Mario Lachat, MD / Dieter O. Mayer, MD | |
Web-Based Presentation | 24.4 - Lessons Learned And Technical Tips For Use Of Snorkel Or Chimney Grafts For Aortic Branch Revascularization |
Presenters(s):David J. Minion, MD | |
Web-Based Presentation | 24.5 - Tips And Tricks With Use Of The Snorkel/Chimney Technique To Facilitate Aortic Debranching And TEVAR |
Presenters(s):W. Charles Sternbergh III, MD | |
END OF SESSION 24 | |
SESSION 25 SCHEDULE | |
Friday
SESSION 25:
NEW DEVELOPMENTS IN THE TREATMENT OF LOWER EXTREMITY ISCHEMIA (5-MINUTE TALKS)
Moderators:Dennis F. Bandyk, MD / Kenneth Ouriel, MD, FACS, FACC
|
|
x | |
8:53 AM - 8:58 AM | What Percentage Of CLI Patients Will Ultimately Need An Open Procedure (Bypass Or Thrombectomy)? |
Presenters(s):Joseph L. Mills, MD | |
8:59 AM - 9:04 AM | When Endovascular Treatment And When Open Bypass For CLI: Do They Both Have A Role? |
Presenters(s):Sean P. Lyden, MD | |
9:05 AM - 9:10 AM | Debate 14: Endovascular Treatment For CLI Is More Cost Effective Than Distal Bypass |
Presenters(s):Luis A. Sanchez, MD | |
9:11 AM - 9:16 AM | Debate 14: For Patients With CLI Endovascular-Only Treatment Is Equally Costly To Open-Only Treatment Even Though Open-Only Was Used On Patients With Worse Disease |
Presenters(s):Nicholas J. Gargiulo III, MD | |
9:17 AM - 9:22 AM | With CLI And Multilevel Disease, When And How Often Will Aortoiliac Recanalization Be Adequate Treatment? |
Presenters(s):Carlo Setacci, MD | |
9:23 AM - 9:28 AM | Endovascular Recanalization Of The Occluded Aorta By A Foolproof Method Using A Reentry Device And Stents To Save Collaterals: Midterm Follow-Up Is Good |
Presenters(s):Ramon L. Varcoe, MD | |
9:29 AM - 9:34 AM | Is Buerger’s Disease Real Or Is It All Peripheral Arteriosclerosis And Should It All Be Treated As Such? |
Presenters(s):Kamphol Laohapensang, MD | |
9:35 AM - 9:40 AM | Use Of A Surrogate Walker And Plantar Bellows To Treat CLI Not Suitable For Endo Or Open Treatment: How Does It Work? |
Presenters(s):Magdiel Trinidad Vasquez, MD | |
9:41 AM - 9:46 AM | Panel Discussion |
Moderator(s): Enrico Ascher, MD / Dhiraj M. Shah, MD | |
9:46 AM - 9:51 AM | Pedal Bypass With Deep Vein Arterialization: A Therapeutic Option In Critical Ischemia With A Poor Distal Outflow Artery |
Presenters(s):Pramook Mutirangura, FRCS (Edinburgh) | |
9:52 AM - 9:57 AM | Debate 15: Progress In Bone Marrow Cell Treatment For CLI: It’s Not All Smoke And Mirrors And It May Save Limbs |
Presenters(s):John (Jeb) W. Hallett, MD | |
9:58 AM - 10:03 AM | Debate 15: Hyperbaric Oxygen And Good Wound Care Do Just As Well As Bone Marrow Cells In CLI |
Presenters(s):William A. Marston, MD | |
10:04 AM - 10:09 AM | BK Pop And Crural Bypasses With Heparin-Bonded PTFE (Propaten): How Well Do They Work? |
Presenters(s):Edward Y. Woo, MD | |
10:10 AM - 10:15 AM | RCT Comparing Propaten PTFE Stretch Grafts To Standard PTFE Stretch Grafts: A Multicenter Study Showing That Heparin Bonding Improves Patency |
Presenters(s):Jes S. Lindholt, MD | |
10:16 AM - 10:21 AM | 4-Year Results With Viabahn Endoluminal Stent Grafts Do As Well As Standard Prosthetic (PTFE And Dacron) Fem-Pop Bypasses For SFA Occlusive Disease In A RCT |
Presenters(s):Dennis R. Gable, MD, FACS | |
10:22 AM - 10:27 AM | High Platelet Count (> 400,000) Is A Predictor Of Early Failure Of Lower Extremity Bypasses: What Should Be Done About It? |
Presenters(s):Glenn M. LaMuraglia, MD | |
10:28 AM - 10:33 AM | Atherosclerotic (Degenerative) Femoral Artery Aneurysms: What Are The Criteria For Repair? |
Presenters(s):Peter F. Lawrence, MD | |
10:34 AM - 10:40 AM | Panel Discussion |
10:40 AM - 10:50 AM | Break / Visit Exhibits and Pavilions (2nd and 3rd Floors) |
Web-Based Presentation | 25.1 - What Is The Optimal Treatment For Mixed Arterial And Venous Ulcers? |
Presenters(s):Richard F. Neville, MD | |
END OF SESSION 25 | |
SESSION 26 SCHEDULE | |
Friday
SESSION 26:
ADVANCES IN MEDICAL TREATMENT AND TREATMENT OF MEDICAL PROBLEMS (5-MINUTE TALKS)
Moderators:Allan D. Callow, MD, PhD / Frank J. Veith, MD
|
|
x | |
10:50 AM - 10:55 AM | Debate 16: Beta Blockade Was Not Beneficial To AAA Repair And Leg Bypass Patients: A Study From The VSGNE Database |
Presenters(s):Jack L. Cronenwett, MD | |
10:56 AM - 11:01 AM | Debate 16: Beta Blockers Don’t Do Much But Statins Are Even Better Than We Realized In Vascular Surgery Patients: What Is The Proper Dosage? |
Presenters(s):Bruce A. Perler, MD, MBA | |
11:02 AM - 11:07 AM | Debate 16: Beta Blockers Are Beneficial In Vascular Surgery Patients And Need Not Increase Stroke Risk: They Just Have To Be Used Properly: What Is Proper Usage? |
Presenters(s):Don Poldermans, MD | |
11:08 AM - 11:13 AM | New Developments In Best Medical Treatment (BMRx): Are There Ways To Raise HDL Or Lower Triglycerides: When Are They Indicated And Do They Help Prevent Atherosclerotic Events? |
Presenters(s):Ron Waksman, MD | |
11:14 AM - 11:19 AM | Present Status And Future Possibilities With Drug Eluting Stents |
Presenters(s):Martin B. Leon, MD | |
11:20 AM - 11:25 AM | Aggressive Lipid Lowering Is Better Than Moderate Lipid Lowering In Stabilizing Carotid Plaques: What Dose Should We Give To Who, And How Does This Dose Change The Plaque? |
Presenters(s):Christos D. Liapis, MD | |
11:26 AM - 11:31 AM | New Opportunities And Best Management With Antiplatelet Therapy For Prevention Of Coronary Stent Thrombosis In Patients Undergoing Vascular Procedures |
Presenters(s):Ron Waksman, MD | |
11:32 AM - 11:37 AM | Should We Measure CRP Before Vascular Procedures: What Does A High CRP Mean And What Can Be Done About It? |
Presenters(s):Henrik Sillesen, MD, DMSc | |
11:38 AM - 11:43 AM | Cardiovascular Disease And Anti-Aging And Regenerative Medicines: A Revolution In Vascular Care |
Presenters(s):Sherif Sultan, MD, FRCS, EBQS-VASC | |
11:44 AM - 11:49 AM | How Low An LDL Level Should We Strive For In Our Vascular Disease Patients And Those Undergoing Procedures: Optimal Statin Dosing |
Presenters(s):Don Poldermans, MD | |
11:50 AM - 11:58 AM | Panel Discussion |
11:58 AM - 1:00 PM | Lunch Break – Visit Exhibits and Pavilions (2nd and 3rd Floors) |
END OF SESSION 26 | |
SESSION 27 SCHEDULE | |
Friday
SESSION 27:
SPECIAL SESSION ON RELATIONSHIPS BETWEEN INDUSTRY, PHYSICIANS, CME AND ADVAMED (7-MINUTE TALKS)
Moderators:Richard A. Baum, MD / Keith D. Calligaro, MD
|
|
x | |
12:03 PM - 12:10 PM | Is The Medical Inquisition Here To Stay: State And Federal Governments, ADVAMED And Some Universities Are Imposing Unfair Restrictions On Physicians And Industry Which Will Prevent Physician Education And Harm Patients: This Witch Hunt Must Stop |
Presenters(s):Zvonimir Krajcer, MD, FACC | |
12:11 PM - 12:18 PM | Rules About CME Are Unreasonable And Part Of A Witch Hunt That Harms CME And Ultimately Will Harm Patients |
Presenters(s):Lowell S. Kabnick, MD, FACS, FACPh | |
12:19 PM - 12:26 PM | What Will Be Lost By Conflict Of Interest Mandates To Separate Practicing Physicians And Surgeons From Industry? |
Presenters(s):Russell H. Samson, MD, RVT, FACS | |
12:27 PM - 12:34 PM | What Will Happen To Large CME Meetings And What Can We Do About It? |
Presenters(s):Barry T. Katzen, MD | |
12:35 PM - 12:42 PM | Redesigning The Relationship Between Physicians And Industry So That Everyone Wins |
Presenters(s):Richard A. Baum, MD | |
12:43 PM - 12:58 PM | Questions And Discussion |
END OF SESSION 27 | |
SESSION 28 SCHEDULE | |
Friday
SESSION 28:
MORE ON THORACIC AORTIC ANEURYSMS (TAAS) AND AAAS AND THEIR TREATMENT AND PREVENTION (5-MINUTE TALKS)
Moderators:Wesley S. Moore, MD / Matt M. Thompson, MD
|
|
x | |
1:00 PM - 1:05 PM | Improved Grafts For TEVAR: The VALIANT And CAPTIVA Systems: Early Results |
Presenters(s):Ronald M. Fairman, MD | |
1:06 PM - 1:11 PM | New Findings From The INSTEAD Trial: Remodeling With And Without Endograft Treatment: What Is The Significance Of The Differing Results? |
Presenters(s):Christoph A. Nienaber, MD, PhD | |
1:12 PM - 1:17 PM | CT Follow-up After EVAR Is Bad For The Kidneys |
Presenters(s):Jan S. Brunkwall, MD, PhD | |
1:18 PM - 1:23 PM | Preoperative Relative AAA Thrombus Burden Predicts Endoleak And Sac Enlargement After EVAR |
Presenters(s):Thomas S. Maldonado, MD | |
1:24 PM - 1:29 PM | Bioenhanced Devices With Local Drug Delivery Have A Role In AAA Treatment |
Presenters(s):Ronald L. Dalman, MD | |
1:30 PM - 1:35 PM | New Technology For Extravascular Or Intravascular Stabilization Of AAAs: The VATRIX System To Influence The AAA Wall |
Presenters(s):Christopher J. Kwolek, MD | |
1:36 PM - 1:41 PM | Debate 17: We Must Have Level I Evidence That EVAR Is Better Than Open Repair For Ruptured AAAs |
Presenters(s):Nicholas J.W. Cheshire, MD | |
1:42 PM - 1:47 PM | Debate 17: EVAR For Ruptured AAAs Is Better: Open Treatment If The Patient Has Favorable Anatomy Is Akin To Murder |
Presenters(s):Sherif Sultan, MD, FRCS, EBQS-VASC | |
1:48 PM - 1:53 PM | How Best To Treat Patients With An AAA And Iliac Occlusive Disease: Tips And Tricks |
Presenters(s):Andrew Holden, MBChB | |
1:54 PM - 1:59 PM | Duplex Ultrasonography Done Early After EVAR Can Predict Which Type II Endoleaks Are Going To Persist And Lead To AAA Sac Enlargement |
Presenters(s):Keith D. Calligaro, MD | |
2:00 PM - 2:05 PM | How Often Does Embolization Of Type II Endoleaks Prevent Sac Expansion: What Can Be Done When It Fails? |
Presenters(s):Timur P. Sarac, MD | |
2:06 PM - 2:12 PM | Panel Discussion |
TOPICS PRESENTED BY TITLE: (SYNCHRONIZED TALKS, SLIDES AND ABSTRACTS THAT WILL BE AVAILABLE ON OUR WEB-BASED VERSION 5 WEEKS AFTER THE MEETING.) | |
Web-Based Presentation | 28.1 - 1-Year Trial Results With The VALIANT Stent-Graft For Treatment Of Complicated Type B Aortic Dissections |
Presenters(s):Matt M. Thompson, MD | |
END OF SESSION 28 | |
SESSION 29 SCHEDULE | |
Friday
SESSION 29:
PROGRESS IN VASCULAR IMAGING FOR INTERVENTIONALISTS (5-MINUTE TALKS)
Moderators:Mark A. Adelman, MD / Nicholas J.W. Cheshire, MD
|
|
x | |
2:12 PM - 2:17 PM | Aneurysm Neck Dynamics As Seen By 4D MRA: How Will It Influence The Choice Of Endograft And EVAR Outcomes? |
Presenters(s):Frans L. Moll, MD, PhD | |
2:18 PM - 2:23 PM | CTA/PET Scanning And Its Value In Diagnosis And Treatment Of Vascular Disease |
Presenters(s):Allan W. Reid, FRCR | |
2:24 PM - 2:29 PM | Dynamic CT Fusion With Prior CTA: How Will It Improve Interventions And Decrease Dye Loads And X-ray Exposure: How Does It Work? |
Presenters(s):Matthew J. Eagleton, MD | |
2:30 PM - 2:35 PM | Value Of 3D Rotational CTA To Facilitate Fenestrated/Branched Endograft Placement |
Presenters(s):Krassi Ivancev, MD, PhD | |
2:36 PM - 2:41 PM | Dual Energy CT In Vascular Imaging: Advantages And Limitations |
Presenters(s):Jos C. van den Berg, MD, PhD | |
2:42 PM - 2:47 PM | Can CTA Evaluate The Circle Of Willis: How Can This Help In CEA And CAS? |
Presenters(s):Michael H. Wholey, MD, MBA | |
2:48 PM - 2:53 PM | Improvements In TeraRecon 3D Imaging For EVAR And TEVAR: It Is Now Easier For Surgeons To Use |
Presenters(s):Mark A. Farber, MD | |
2:54 PM - 2:59 PM | Progress In The Value Of IVUS And Virtual Histology In Various Vascular Beds |
Presenters(s):Donald B. Reid, MD | |
3:00 PM - 3:05 PM | Pre And Post Procedural Imaging For Lower Extremity Arteriosclerosis: Which Is Best And How To Make Them Better With 3D Post Processing |
Presenters(s):Barry Stein, MD, FSIR, FACR | |
3:06 PM - 3:11 PM | Panel Discussion and Break – Visit Exhibits and Pavilions (2nd and 3rd Floors) |
END OF SESSION 29 | |
SESSION 30 SCHEDULE | |
Friday
SESSION 30:
PROGRESS IN VENOUS DISEASE AND ITS TREATMENT (5-MINUTE TALKS) – PART I
Moderators:Bo G. Eklof, MD, PhD / Ramesh K. Tripathi, MD, FRCS, FRACS
|
|
x | |
3:19 PM - 3:24 PM | RCT Comparison Of IVC Filters: Greenfield vs. TrapEase: Which Causes More Caval Thrombosis? |
Presenters(s):Anil P. Hingorani, MD | |
3:25 PM - 3:30 PM | Debate 18: The Greater Saphenous Vein Should Be Preserved When Treating Most Varicose Veins |
Presenters(s):Paul Pittaluga, MD | |
3:31 PM - 3:36 PM | Debate 18: The Greater Saphenous Vein Should Almost Never Be Preserved When Treating Varicose Veins |
Presenters(s):Peter Gloviczki, MD | |
3:37 PM - 3:42 PM | Complications Of Radiofrequency And Laser Endovenous Ablation |
Presenters(s):Mark H. Meissner, MD | |
3:43 PM - 3:48 PM | Reduction Of Venous Ulcers By 50%: Is That Feasible In The U.S. In 10 Years? Report From American Venous Forum’s Expert Meeting In Hawaii November 2009 |
Presenters(s):Bo G. Eklof, MD, PhD | |
3:49 PM - 3:54 PM | Debate 19: Deep Venous Thrombectomy With AVF: It Still Has A Role In The Endovascular Era |
Presenters(s):Wilhelm Sandmann, MD | |
3:55 PM - 4:00 PM | Debate 19: Catheter Directed Thrombolysis Is The Best Treatment For Most Patients With Ileofemoral DVT: It Decreases Postphlebitic Syndrome And Recurrent DVT |
Presenters(s):Anthony J. Comerota, MD, FACS, FACC | |
4:01 PM - 4:06 PM | Debate 19: Anticoagulation Is Best For Most DVT Patients: The Only Reason For The Endovascular Treatment Of DVT Is To Provide Business For Interventionalists |
Presenters(s):Erich Minar, MD | |
4:07 PM - 4:12 PM | Tips And Tricks For Performing Lytic Treatment For DVT: Technique Matters |
Presenters(s):Thomas O. McNamara, MD | |
4:13 PM - 4:18 PM | Panel Discussion |
Moderator(s): Mark H. Meissner, MD / Joann Lohr, MD | |
4:19 PM - 4:24 PM | Treatment Of Pulmonary Emboli With Catheter Directed Ultrasound (EKOS) Thrombolysis: A Better Way |
Presenters(s):Peter H. Lin, MD | |
4:25 PM - 4:30 PM | Safety, Value And Advantages Of A New Ultrasound Technique (EKOS) For Thrombolysis In DVT |
Presenters(s):Frank R. Arko, MD | |
4:31 PM - 4:36 PM | Inflammatory Biomarkers That Allow A Blood Test Diagnosis Of DVT |
Presenters(s):Thomas W. Wakefield, MD | |
4:37 PM - 4:42 PM | Hyperbaric Oxygen Therapy Is More Effective Clinically And In Terms Of Cost Than Compression Treatment For Refractory Venous Ulcers |
Presenters(s):Niamh Hynes, MD | |
4:43 PM - 4:48 PM | Panel Discussion |
TOPICS PRESENTED BY TITLE: (SYNCHRONIZED TALKS, SLIDES AND ABSTRACTS THAT WILL BE AVAILABLE ON OUR WEB-BASED VERSION 5 WEEKS AFTER THE MEETING.) | |
Web-Based Presentation | 30.1 - Further Experience With The ROTAREX Device In The Treatment Of Massive Pulmonary Emboli |
Presenters(s):Marcelo Ferreira, MD | |
Web-Based Presentation | 30.2 - Discovery Of Venous Valves: Myth Or Reality? |
Presenters(s):J. Leonel Villavicencio, MD | |
END OF SESSION 30 | |
SESSION 31 SCHEDULE | |
Friday
SESSION 31:
PROGRESS IN VENOUS DISEASE (5-MINUTE TALKS) – PART II
Moderators:J. Leonel Villavicencio, MD / Seshadri Raju, MD
|
|
x | |
4:48 PM - 4:53 PM | Advances In Venous Disease Research In 2010 |
Presenters(s):Mark H. Meissner, MD | |
4:54 PM - 4:59 PM | Complications After IVC Retrievable Filters Can Damage Adjacent Structures: How To Prevent Such Damage |
Presenters(s):Kim J. Hodgson, MD | |
5:00 PM - 5:05 PM | The NOVATE Bioconvertible IVC Filter: The Next Generation Device Where The Filter Converts To A Stent |
Presenters(s):David Rosenthal, MD | |
5:06 PM - 5:11 PM | Debate 20: We Need Stricter Criteria For Use Of Caval Interruption Devices |
Presenters(s):David L. Gillespie, MD | |
5:12 PM - 5:17 PM | Debate 20: We Do Not Need Stricter Criteria For Use Of Caval Interruption Devices |
Presenters(s):Michael C. Dalsing, MD | |
5:18 PM - 5:23 PM | Indications And Technique For Treating Popliteal Venous Aneurysms: Why Are They Dangerous? |
Presenters(s):Fredric Jarrett, MD | |
5:24 PM - 5:29 PM | Debate 21: Stents Are Usually Required In The Endovascular Treatment Of Chronic Venous Disease |
Presenters(s):Seshadri Raju, MD | |
5:30 PM - 5:35 PM | Debate 21: Stents Are Best Avoided In The Endovascular Treatment Of Chronic Venous Disease |
Presenters(s):Gregory L. Moneta, MD | |
5:36 PM - 5:41 PM | How To Deal With The Large Marginal Lateral Vein In Klippel Trenaunay Syndrome Patients: Excision, Laser, Foam Or Retreat? |
Presenters(s):J. Leonel Villavicencio, MD | |
5:42 PM - 5:47 PM | Best Practice Guidelines For Managing Venous Ulcers: What Is Best And What Is Really Being Done In The US And Europe? |
Presenters(s):Thomas F. O'Donnell, Jr., MD | |
5:48 PM - 5:53 PM | Conservative Treatment With Compression And Antiplatelet Agents Is As Effective As Anticoagulation With Isolated Gastrocnemius Or Soleal DVT |
Presenters(s):Clifford M. Sales, MD, MBA | |
5:54 PM - 5:59 PM | Aggressive Treatment Of Chronic DVT With Thrombolysis And Mechanical Clot Removal: When Is It Indicated And Does It Work? |
Presenters(s):Mark J. Garcia, MD | |
6:00 PM - 6:05 PM | Panel Discussion |
TOPICS PRESENTED BY TITLE: (SYNCHRONIZED TALKS, SLIDES AND ABSTRACTS THAT WILL BE AVAILABLE ON OUR WEB-BASED VERSION 5 WEEKS AFTER THE MEETING.) | |
Web-Based Presentation | 31.1 - Endovascular And Combined Endovascular-Surgical Treatment For DVT |
Presenters(s):Jos C. van den Berg, MD, PhD | |
Web-Based Presentation | 31.2 - Why Is Screening For Venous Disease Important: 5-Year Report From The National Venous Screening Program Of The AVF |
Presenters(s):Marc A. Passman, MD | |
Web-Based Presentation | 31.3 - The CHIVA Procedure For Leaving The Greater Saphenous Vein Intact When Treating Varicose Veins: Why Does It Work? |
Presenters(s):Mohan Adiseshiah, FRCS | |
Web-Based Presentation | 31.4 - Endovascular Treatment Of Varicocele And Pelvic Congestion Syndrome: Technique And Results |
Presenters(s):Peter H. Lin, MD | |
END OF SESSION 31 | |
Saturday, November 20, 2010
Print Entire 2010 Program:
|
|
SESSION 32 SCHEDULE | |
Saturday
SESSION 32:
NEW DEVELOPMENTS IN ANEURYSMS AND THEIR TREATMENT: EVAR, THE TRIALS, LAPAROSCOPIC METHODS (5-MINUTE TALKS)
Moderators:Michael L. Marin, MD / Robert B. Rutherford, MD
|
|
x | |
6:40 AM - 6:45 AM | Anaconda Endograft For Juxtarenal AAAs: An “Off-the-Shelf” Solution To The Short (3-10 mm) Infrarenal Neck: Technical Details With The Possible Use Of Supplementary Stents |
Presenters(s):Randy D. Moore, MD | |
6:46 AM - 6:51 AM | Modifiable And Unmodifiable Predictors Of Preoperative Mortality And Morbidity In Open AAA Repair |
Presenters(s):Gregory L. Moneta, MD | |
6:52 AM - 6:57 AM | Best Strategy For Treating Huge AAAs > 15 cm In Diameter: Open vs. Endo |
Presenters(s):Jacques Busquet, MD | |
6:58 AM - 7:03 AM | Renal Artery Revascularization By Totally Laparoscopic Techniques |
Presenters(s):Jerome Cau, MD / Yves S. Alimi, MD | |
7:04 AM - 7:09 AM | Debate 22: Rupture After EVAR Is More Benign Than The Usual Ruptured AAA |
Presenters(s):James May, MD, MS, FRACS, FACS | |
7:10 AM - 7:15 AM | Debate 22: Rupture After EVAR Is Not More Benign Than The Usual Ruptured AAA |
Presenters(s):Michel S. Makaroun, MD | |
7:16 AM - 7:21 AM | New From The EVAR Trial: Mortality Catch-Up After EVAR: What Is It Due To? |
Presenters(s):Louise C. Brown, PhD / Roger M. Greenhalgh, MD / Janet T. Powell, MD, PhD | |
7:22 AM - 7:27 AM | How To Do Open AAA Repair Of Large AAAs Through A Tiny Incision |
Presenters(s):Tomislav Klokocovnik, PhD | |
7:28 AM - 7:33 AM | Panel Discussion |
Moderator(s): K. Wayne Johnston, MD, FRCS / Frank J. Veith, MD | |
7:33 AM - 7:38 AM | Debate 23: Short-Term And Long-Term Outcomes After EVAR And Open Repair Of RAAAs From The Medicare Database: They Are Equally Bad For Open And Endo |
Presenters(s):Mark Conrad, MD | |
7:39 AM - 7:44 AM | Debate 23: Single Center Outcomes Of EVAR And Open Repair For Ruptured AAAs: The Short-Term Survival Benefit Of EVAR Is Sustained Long-Term |
Presenters(s):Dieter O. Mayer, MD | |
7:45 AM - 7:50 AM | More That Is New From The EVAR Trials: Rupture After EVAR Is More Common Than After Open Repair Of AAAs Shown In The EVAR UK Trials I And II |
Presenters(s):Thomas R. Wyss, MD / Louise C. Brown, PhD / Janet T. Powell, MD, PhD / Roger M. Greenhalgh, MD | |
7:51 AM - 7:56 AM | What Is New From The DREAM Trial: Are There Long-Term Survival Benefits Of EVAR? |
Presenters(s):Jan D. Blankensteijn, MD | |
7:57 AM - 8:02 AM | 5-Year Results Of The French ACE Trial Comparing EVAR With Open Repair In Standard Risk Patients |
Presenters(s):Jean-Pierre Becquemin, MD, FRCS | |
8:03 AM - 8:08 AM | What Is New From The OVER VA Trial Of EVAR vs. Open Repair For Standard Risk AAAs? |
Presenters(s):Frank A. Lederle, MD | |
8:09 AM - 8:14 AM | Panel Discussion |
TOPICS PRESENTED BY TITLE: (SYNCHRONIZED TALKS, SLIDES AND ABSTRACTS THAT WILL BE AVAILABLE ON OUR WEB-BASED VERSION 5 WEEKS AFTER THE MEETING.) | |
Web-Based Presentation | 32.1 - Innovation In AAA Diagnosis And Treatment: What Does The Future Hold? |
Presenters(s):Vicente Riambau, MD, PhD | |
Web-Based Presentation | 32.2 - Does AAA Diameter Influence Long-Term Patient Survival After Elective EVAR And Open Repair? |
Presenters(s):Peter Polterauer, MD / Hans Teufelsbauer, MD / George Kretschmer, MD / Johannes Lammer, MD | |
Web-Based Presentation | 32.3 - Why Is The Mortality For Elective And Ruptured AAA Repair (Open And Endo) So Much Higher In Women? Can It Be Fixed? |
Presenters(s):Marc R.H. van Sambeek, MD, PhD | |
Web-Based Presentation | 32.4 - Tips And Tricks For Open Conversion After Failed EVAR |
Presenters(s):R. Clement Darling III, MD | |
Web-Based Presentation | 32.5 - Are Outcomes For Hemodynamically Stable Ruptured AAA Patients Different From Those Who Are Unstable? |
Presenters(s):Manish Mehta, MD, MPH | |
END OF SESSION 32 | |
SESSION 33 SCHEDULE | |
Saturday
SESSION 33:
NEW DEVELOPMENTS IN THE TREATMENT OF THE AORTA AND ITS BRANCHES (5-MINUTE TALKS)
Moderators:Wesley S. Moore, MD / Jean-Pierre Becquemin, MD, FRCS
|
|
x | |
8:14 AM - 8:19 AM | A Telescoping Sutureless Aortic Anastomosis Using An Endograft Connector For Aortoiliac Occlusive Disease In Which The Aorta Cannot Be Clamped Or Sewn Due To Calcification Or Scarring: A New Hybrid Technique |
Presenters(s):Mario Lachat, MD | |
8:20 AM - 8:25 AM | Debate 24: Open Surgery Is Never Needed For Aortoiliac Occlusive Disease |
Presenters(s):Edward B. Diethrich, MD | |
8:26 AM - 8:31 AM | Debate 24: Aortoiliac Stents Are Not All They Are Cracked Up To Be: Open Surgery Is Sometimes Better |
Presenters(s):Rabih A. Chaer, MD / Michel S. Makaroun, MD | |
8:32 AM - 8:37 AM | Aortoiliac Occlusions Should First Be Treated Endovascularly: Do Any Require Open Surgery? |
Presenters(s):Götz M. Richter, MD, PhD | |
8:38 AM - 8:43 AM | Contemporary Management Of Splenic Artery Aneurysms: Indications For Endo And Open Treatment |
Presenters(s):Vikram S. Kashyap, MD | |
8:44 AM - 8:49 AM | A New Concept For A Branched Endograft For Left Subclavian Revascularization With TEVAR |
Presenters(s):Frank R. Arko, MD | |
8:50 AM - 8:55 AM | Minimally Invasive Treatment Of Visceral Aneurysms: When Can It Work, When Can It Not? |
Presenters(s):Samuel R. Money, MD, MBA | |
8:56 AM - 9:01 AM | Visceral Aneurysms: Role Of Open And Endovascular Treatments |
Presenters(s):Arno von Ristow, MD | |
9:02 AM - 9:07 AM | Panel Discussion |
Moderator(s): Darren B. Schneider, MD / Ramesh K. Tripathi, MD, FRCS, FRACS | |
9:08 AM - 9:13 AM | Current Status Of Renal Artery Stenting: It Is Not Dead But Why Is It So Hard To Prove Its Value? |
Presenters(s):Peter A. Schneider, MD | |
9:14 AM - 9:19 AM | Improved Stents, Balloons And Embolic Protection Devices (EPDs) For Renal Artery Stenting |
Presenters(s):Thomas Zeller, MD | |
9:20 AM - 9:25 AM | Errors In Selection Criteria For Renal Artery PTA And Stenting: There Is Still A Role For Open Repair |
Presenters(s):James C. Stanley, MD | |
9:26 AM - 9:31 AM | Debate 25: There Is No Need For EPDs In Renal Artery Stenting If One Uses Optimal Techniques |
Presenters(s):Ali Amin, MD, RVT, FACS, FACC | |
9:32 AM - 9:37 AM | Debate 25: EPDs Should Be Used In Renal Artery Stenting Whenever Possible |
Presenters(s):Max Amor, MD | |
9:38 AM - 9:43 AM | For Chronic Visceral Ischemia When Is Endovascular Treatment Indicated And When Is Open Surgical Repair The Best Treatment? |
Presenters(s):Gustavo S. Oderich, MD | |
9:44 AM - 9:55 AM | Panel Discussion And Break – Visit Exhibits and Pavilions (2nd and 3rd Floors) |
TOPICS PRESENTED BY TITLE: (SYNCHRONIZED TALKS, SLIDES AND ABSTRACTS THAT WILL BE AVAILABLE ON OUR WEB-BASED VERSION 5 WEEKS AFTER THE MEETING.) | |
Web-Based Presentation | 33.1 - How Should Renal Artery In Stent Restenosis And Stent Fractures Be Best Treated? |
Presenters(s):Robert A. Lookstein, MD, FSIR, FAHA | |
Web-Based Presentation | 33.2 - Renal Artery Stents Perform Poorly: We Need Covered Or Otherwise Modified Stents |
Presenters(s):Ross Milner, MD | |
Web-Based Presentation | 33.3 - Should We Forget About Aortoiliac Endarterectomy? |
Presenters(s):Timothy M. Sullivan, MD | |
Web-Based Presentation | 33.4 - Indications And Value Of Hypogastric Artery Stenting |
Presenters(s):Götz M. Richter, MD, PhD | |
Web-Based Presentation | 33.5 - Flaws In The ASTRAL And CORAL Trials: Renal Artery Stenting Still Has A Role |
Presenters(s):Michael H. Wholey, MD, MBA | |
Web-Based Presentation | 33.6 - Upper Extremity Access For Renal Artery Stenting: Radial, Brachial And Axillary Access: How To Do Them Safely And Pitfalls To Avoid |
Presenters(s):Thomas A. Sos, MD | |
Web-Based Presentation | 33.7 - Tips And Tricks For Subintimal Angioplasty For Iliac Occlusions: Open Operation May Be Obsolete |
Presenters(s):Jean M. Panneton, MD | |
Web-Based Presentation | 33.8 - Iliac Artery Entrapment In Cyclists: Diagnosis And Treatment |
Presenters(s):Alun H. Davies, MA, DM, FRCS, FHEA | |
Web-Based Presentation | 33.9 - Importance Of Fractures In Renal Artery Stenting: How To Prevent Them |
Presenters(s):Michael H. Wholey, MD, MBA | |
END OF SESSION 33 | |
SESSION 34 SCHEDULE | |
Saturday
SESSION 34:
THE FUTURE: ISSUES REGARDING HEALTH CARE CONCEPTS (5-MINUTE TALKS)
|
|
x | |
9:55 AM - 10:00 AM | Debate 26: Should Major Vascular Procedures Be Centralized: Yes – It Is Best For All Concerned |
Presenters(s):Matt M. Thompson, MD | |
10:01 AM - 10:06 AM | Debate 26: Should Major Vascular Procedures Be Centralized: Hell No – It Can Never Be Done |
Presenters(s):Karl A. Illig, MD | |
10:07 AM - 10:12 AM | Impact Of Health Care Reform On Vascular Surgery And Its Practice |
Presenters(s):Robert M. Zwolak, MD, PhD | |
10:13 AM - 10:18 AM | What Is Health Care Reform All About: Will It Hurt Vascular Surgery, Health Care In General And Our Country: How? |
Presenters(s):Thomas J. Fogarty, MD | |
10:19 AM - 10:24 AM | Surgeon And Physician Interaction With Device And Pharmaceutical Companies: What Is Going On In Massachusetts And Is This The Canary In The Coal Mine Before The Explosion: What Can Be Done About It? |
Presenters(s):Thomas F. O'Donnell, Jr., MD | |
10:25 AM - 10:30 AM | A View From Industry: The Negative Impact And Unintended Consequences Of Health Care Reform: What Can Be Done About It? |
Presenters(s):Tammy S. Leitsinger, BSM | |
10:31 AM - 10:36 AM | Changes In Coding And Reimbursement For Endovascular Lower Extremity Intervention In 2011 |
Presenters(s):Sean P. Roddy, MD | |
10:36 AM - 10:44 AM | Panel Discussion |
END OF SESSION 34 | |
SESSION 35 SCHEDULE | |
Saturday
SESSION 35:
A TRIBUTE TO OUR MILITARY (5-MINUTE TALKS)
Moderators:David L. Gillespie, MD / Norman M. Rich, MD, FACS, DMCC
|
|
x | |
10:44 AM - 10:49 AM | Task Force Leatherneck: A Surgeon’s Perspective From Afghanistan |
Presenters(s):Stephen F. McCartney, MD, FACS | |
10:50 AM - 10:55 AM | Vascular Injury Rates In The Iraq And Afghanistan Wars: How Are They Different From The Past? |
Presenters(s):Todd E. Rasmussen, MD, FACS | |
10:56 AM - 11:01 AM | Some Historical Vignettes In Vascular Surgery: Who Did What First? |
Presenters(s):Norman M. Rich, MD, FACS, DMCC | |
11:02 AM - 11:07 AM | Panel Discussion |
END OF SESSION 35 | |
SESSION 36 SCHEDULE | |
Saturday
SESSION 36:
COST, TRAINING, AND BUSINESS ISSUES (5-MINUTE TALKS)
Moderators:Robert M. Zwolak, MD, PhD / Karl A. Illig, MD
|
|
x | |
11:08 AM - 11:13 AM | How Can Device And Supply Costs For Endovascular Procedures Be Minimized By A Computerized Management System With Vascular Surgeon Input? |
Presenters(s):Jerry Goldstone, MD, FACS, FRCS E | |
11:14 AM - 11:19 AM | Simplified Billing And Coding Software To Facilitate Recordkeeping And Billing And Save Time And Energy In A Vascular Practice |
Presenters(s):Sam S. Ahn, MD, FACS, MBA | |
11:20 AM - 11:25 AM | Do Popular Media And Internet Hospital Quality Ratings Identify Hospitals With Better Cardiovascular Surgery Outcomes? |
Presenters(s):Gilbert R. Upchurch, MD | |
11:26 AM - 11:31 AM | FDA Perspective On Current Challenges Facing Clinical Evaluation Of Peripheral Vascular Devices |
Presenters(s):Kenneth J. Cavanaugh, Jr., PhD / Dorothy B. Abel, BSBME | |
11:32 AM - 11:37 AM | Robotics And Endovascular Navigation: Progress In And Importance For In Situ Fenestration And Other Complex Procedures |
Presenters(s):Nicholas J.W. Cheshire, MD | |
11:38 AM - 11:43 AM | 3D Endovascular Mechanical Simulator System (The Pontressina System): A Valuable New Approach To Improve Simulator Training |
Presenters(s):Hans-Henning Eckstein, MD, PhD | |
11:44 AM - 11:49 AM | How To Set Up A Comprehensive Diabetes Program |
Presenters(s):Peter Sheehan, MD | |
11:50 AM - 11:55 AM | Cost Impact Of Statins In AAA Repair: They Make A Difference |
Presenters(s):Michael C. Stoner, MD | |
11:55 AM - 12:00 PM | Panel Discussion |
TOPICS PRESENTED BY TITLE: (SYNCHRONIZED TALKS, SLIDES AND ABSTRACTS THAT WILL BE AVAILABLE ON OUR WEB-BASED VERSION 5 WEEKS AFTER THE MEETING.) | |
Web-Based Presentation | 36.1 - How Can Endovascular Procedures Be Done Effectively And In A Freestanding Outpatient Facility To Keep It In The Black? |
Presenters(s):Russell H. Samson, MD, RVT, FACS | |
END OF SESSION 36 | |
SESSION 37 SCHEDULE | |
Saturday
SESSION 37:
LUNCHEON LECTURES: NEW AND IMPROVED ENDOGRAFTS, TECHNIQUES AND DEVICES (5-MINUTE TALKS)
Moderators:Frans L. Moll, MD, PhD / Giorgio M. Biasi, MD
|
|
x | |
12:00 PM - 12:05 PM | The Improved TRIVASCULAR Graft: History, Improvements, Advantages And Recent And Long-Term Clinical Experience |
Presenters(s):Michael D. Dake, MD / Francisco Valdes, MD | |
12:06 PM - 12:11 PM | The NELLIX EVAR Endoprosthesis For Filling The AAA Sac With Polymer Filled Endobags While Maintaining Flow Through Stents: Technique, Early Results And Advantages |
Presenters(s):Carlos E. Donayre, MD | |
12:12 PM - 12:17 PM | Contemporary 1-Year EVAR Outcomes From The U.S. IDE Trial And ENGAGE Global Registry Of The ENDURANT AAA Endograft Device |
Presenters(s):Michel S. Makaroun, MD / Vicente Riambau, MD, PhD | |
12:18 PM - 12:23 PM | Update On The US RELAY Trial For TEVAR |
Presenters(s):Mark A. Farber, MD | |
12:24 PM - 12:29 PM | Multicenter Clinical Experience With A Novel Repositionable AAA Endograft From W.L. Gore & Associates |
Presenters(s):Eric L.G. Verhoeven, MD, PhD / Mark F. Fillinger, MD | |
12:30 PM - 12:35 PM | Advantages Of The Improved COOK TX2 Device For TEVAR |
Presenters(s):Karl A. Illig, MD | |
12:36 PM - 12:41 PM | Advantages And Limitations Of The ANACONDA AAA Endograft |
Presenters(s):Donald B. Reid, MD | |
12:42 PM - 12:47 PM | Update On The APTUS Devices And Trials |
Presenters(s):Mark A. Adelman, MD | |
12:48 PM - 12:53 PM | Update On The Aorfix AAA Graft For Angulated Necks And Severe Iliac Angulation: The European 8-Year Results |
Presenters(s):Brian R. Hopkinson, ChM, FRCS | |
12:54 PM - 12:59 PM | Off-The-Shelf Fenestrated Device From Endologix For Treatment Of Pararenal And Juxtarenal AAAs: Initial Clinical Experience |
Presenters(s):Daniel G. Clair, MD | |
12:59 PM - 1:04 PM | Panel Discussion |
TOPICS PRESENTED BY TITLE: (SYNCHRONIZED TALKS, SLIDES AND ABSTRACTS THAT WILL BE AVAILABLE ON OUR WEB-BASED VERSION 5 WEEKS AFTER THE MEETING.) | |
Web-Based Presentation | 37.1 - Advantages Of The Cook ZENITH LP Device For AAAs |
Presenters(s):Ronald M. Fairman, MD | |
Web-Based Presentation | 37.2 - Update On The US ANACONDA Trial |
Presenters(s):Christopher J. Kwolek, MD | |
Web-Based Presentation | 37.3 - 3-Year Results With The Cook RENU Proximal Cuff Device For Treating Failed/Migrated Endografts Without Or With Type I Leaks |
Presenters(s):Luis A. Sanchez, MD | |
Web-Based Presentation | 37.4. - European Experience With The RELAY Endograft In 304 TEVAR Cases |
Presenters(s):Vicente Riambau, MD, PhD | |
Web-Based Presentation | 37.5 - Significant Reduction Of Aneurysm Volumes After EVAR With Excluder Low Permeability Graft: Comparison With Original Excluder After 4 Years Of Follow-Up |
Presenters(s):Zvonimir Krajcer, MD, FACC | |
Web-Based Presentation | 37.6 - One-Year Clinical Experience With The TriVascular OvationT Abdominal Stent Graft |
Presenters(s):Francisco Valdes, MD | |
END OF SESSION 37 | |
SESSION 38 SCHEDULE | |
Saturday
SESSION 38:
ETHICS, STANDARDS, CONCEPTS, MALPRACTICE (5-MINUTE TALKS)
Moderators:Julius H. Jacobson II, MD / Norman M. Rich, MD, FACS, DMCC
|
|
x | |
1:05 PM - 1:09 PM | Off-Label Device Use: An FDA Division of Cardiovascular Devices Perspective |
Presenters(s):Dorothy B. Abel, BSBME | |
1:10 PM - 1:15 PM | Are There Alternate Pathways To FDA Approval Of Vascular Devices That We Can Use? |
Presenters(s):Rodney A. White, MD | |
1:16 PM - 1:21 PM | Off-Label Use Of A Drug Or Device Or Use Of A New Device With Little Experience Can Lead To Malpractice Liability |
Presenters(s):O. William Brown, MD, JD | |
1:22 PM - 1:27 PM | How To Be A Good Expert Witness |
Presenters(s):Karl A. Illig, MD | |
1:28 PM - 1:33 PM | Surgical Infomercials The Ethical Price Of Stardom: But Are They Right? |
Presenters(s):James W. Jones, MD, PhD, MHA | |
1:34 PM - 1:39 PM | The Social (Public) Media And Their Impact On Patient Care, Patient Recruitment And Patient-Physician Interaction |
Presenters(s):Grayson H. Wheatley, MD | |
1:40 PM - 1:45 PM | Does Stent Placement Have A Learning Curve: What Mistakes Do We As Operators Make And How Can They Be Avoided? |
Presenters(s):Lewis B. Schwartz, MD | |
1:46 PM - 1:51 PM | Is Red Wine Really Helpful For Vascular Disease Patients: Why And What Dose Is Best? |
Presenters(s):Bauer E. Sumpio, MD, PhD | |
1:52 PM - 1:57 PM | Panel Discussion |
TOPICS PRESENTED BY TITLE: (SYNCHRONIZED TALKS, SLIDES AND ABSTRACTS THAT WILL BE AVAILABLE ON OUR WEB-BASED VERSION 5 WEEKS AFTER THE MEETING.) | |
Web-Based Presentation | 38.1 - What Motivates Us As Vascular Specialists To Perform Procedures Other Than Patient Benefit? |
Presenters(s):Frank J. Veith, MD | |
Web-Based Presentation | 38.2 - Are Some Centers With Good Mortality And Morbidity Results For AAA Repair, Etc., Guilty Of Turning Down Bad Patients: Does This Render Quality Evaluations Difficult? |
Presenters(s):Matt M. Thompson, MD | |
Web-Based Presentation | 38.3 - Assessing Quality And Risk In Our Health Care System: The Good, The Bad And The Ugly: Is PFP Going To Be Fair And Beneficial Or Bad? |
Presenters(s):Ralph G. DePalma, MD | |
END OF SESSION 38 | |
SESSION 39 SCHEDULE | |
Saturday
SESSION 39:
VASCULAR DISEASE NATURAL HISTORY, MEDICAL TREATMENT, PREVENTION AND TREATMENT OF COMPLICATIONS (5-MINUTE TALKS)
Moderators:Peter R.F. Bell, MD, FRCS, DSC, KBE / Sharif H. Ellozy, MD
|
|
x | |
1:58 PM - 2:03 PM | Can Medication Stabilize Or Reverse Vascular Disease: With Lipid Lowering How Low Should You Go? |
Presenters(s):Russell H. Samson, MD, RVT, FACS | |
2:04 PM - 2:09 PM | RHEOS Trial Update: Carotid Sinus Stimulation For Treatment Of Drug Resistant Hypertension: Does It Work? |
Presenters(s):Luis A. Sanchez, MD | |
2:10 PM - 2:15 PM | Influence Of ACE Inhibitors And Statins On AAA Growth And Rupture Risk: Do They Make A Difference And Why? |
Presenters(s):Janet T. Powell, MD, PhD | |
2:16 PM - 2:21 PM | Are ACE Inhibitors Of Value In Patients With Thoracic Aortic Aneurysms? |
Presenters(s):Iris Baumgartner, MD | |
2:22 PM - 2:27 PM | Is The Cervical Approach For CAS With Flow Reversal Safer For The Brain Than Other CAS Approaches: Based On DWI MRI |
Presenters(s):Enrique Criado, MD, FACS | |
2:28 PM - 2:33 PM | ONYX As An Adjunct In Treating Type I And Type II Endoleaks, Ruptured AAAs And Arterial Injuries: An Update |
Presenters(s):Thomas Larzon, MD | |
2:34 PM - 2:39 PM | New Developments In Statin Treatment Of Importance To Vascular Specialists And Their Patients: Which Statin; What Dosage? |
Presenters(s):Kosmas I. Paraskevas, MD | |
2:40 PM - 2:45 PM | Endovascular Solutions To Aortoiliac Complications From Spine Surgery |
Presenters(s):Neal S. Cayne, MD | |
2:46 PM - 2:51 PM | Drug Eluting Stents Are Great For Coronary Artery Disease Patients But Trouble For Vascular Surgeons: How To Get Them Through Surgery If They Have A Drug Eluting Stent |
Presenters(s):Jean-Pierre Becquemin, MD, FRCS | |
2:52 PM - 2:57 PM | Panel Discussion |
TOPICS PRESENTED BY TITLE: (SYNCHRONIZED TALKS AND SLIDES THAT WILL BE AVAILABLE ON OUR WEB-BASED VERSION 5 WEEKS AFTER THE MEETING.) | |
Web-Based Presentation | 39.1 - Can Hybrid Open Chest Procedures Be Done Safely In A Modified Angio Suite? |
Presenters(s):Barry T. Katzen, MD | |
Web-Based Presentation | 39.2 - Vascular Surgeons Must Lead The Efforts For Their Patients To Get Proper Statin Treatment |
Presenters(s):Anthony J. Comerota, MD, FACS, FACC | |
Web-Based Presentation | 39.3 - What Is The Role Of A Cervical Approach For CAS: How To Do It Safely? |
Presenters(s):Mark H. Wholey, MD | |
Web-Based Presentation | 39.4 - Endovascular Rescue Of Inadvertent Arterial Sheath Placement During Central Venous Catheterization: How To Recognize And Treat |
Presenters(s):Tilo Kölbel, MD, PhD | |
Web-Based Presentation | 39.5 - Effect Of Statins On Early And Late Results Of CAS |
Presenters(s):Piergiorgio Cao, MD, FRCS | |
Web-Based Presentation | 39.6 - How To Solve The Problem Of Catching Or Snagging Wires During EVAR |
Presenters(s):Barry T. Katzen, MD | |
END OF SESSION 39 | |
SESSION 40 SCHEDULE | |
Saturday
SESSION 40:
UPDATES, NEW TECHNIQUES AND CONCEPTS (5-MINUTE TALKS)
Moderators:George H. Meier III, MD / Lucien D. Castellani, MD
|
|
x | |
2:57 PM - 3:02 PM | Have Endovascular Treatments Altered The Management And Outcomes Of Acute Mesenteric Ischemia? |
Presenters(s):Daniel G. Clair, MD | |
3:03 PM - 3:08 PM | Transvenous Transcaval Approach To AAA Sacs After EVAR To Treat Type II Endoleaks |
Presenters(s):Giancarlo Mansueto, MD | |
3:09 PM - 3:14 PM | What Happens To The Femoral Artery With Manual Compression Hemostasis After Endovascular Procedures; Is It Totally Benign? |
Presenters(s):Dusan Pavcnik, MD, PhD | |
3:15 PM - 3:20 PM | Unusual Uses Of The ANACONDA Endograft And Its Components In Special Circumstances |
Presenters(s):Andrea Stella, MD | |
3:21 PM - 3:26 PM | Use Of Covered Palmaz Stent (VI-Maquet) For Solving Difficult Neck Problems With EVAR |
Presenters(s):Giovanni P. Deriu, MD | |
3:27 PM - 3:32 PM | Use Of Covered And Uncovered Palmaz Stents To Resolve Difficult Neck Problems With EVAR: When Is A Covered Stent Needed? |
Presenters(s):Dieter Raithel, MD, PhD | |
3:33 PM - 3:38 PM | Femoro-femoral Stabilizing Second Wire For Complex Hypogastric Artery Embolizations: Advantages And Technique |
Presenters(s):Jon S. Matsumura, MD | |
3:39 PM - 3:44 AM | What To Do During CAS With Flow Reversal If It Is Not Tolerated – Especially With Contralateral ICA Occlusion: How Can The Procedure Be Completed Safely With Embolic Protection? |
Presenters(s):Karthikeshwar Kasirajan, MD | |
3:45 PM - 3:50 PM | Panel Discussion |
Moderator(s): John E. Connolly, MD / Donna M. Mendes, MD, FACS | |
3:50 PM - 3:55 PM | Debate 27: Suprarenal Fixation Is Best For Angled Necks |
Presenters(s):Bjõrn Sonesson, MD, PhD / Martin Malina, MD, PhD | |
3:56 PM - 4:01 PM | Debate 27: Suprarenal Fixation Is Not Best For Angled Necks |
Presenters(s):Robert Y. Rhee, MD | |
4:02 PM - 4:07 PM | Femoral Endarterectomy And Iliac Stent-Grafting vs. Aortobifemoral Bypass: When Should The Former Replace The Latter? |
Presenters(s):Richard J. Powell, MD | |
4:08 PM - 4:13 PM | New Developments With The CARDIOMEMS Pressure Monitoring Device: When Is Its Use Beyond A Research Tool Justified? |
Presenters(s):Ross Milner, MD | |
4:14 PM - 4:19 PM | Coiling Techniques To Treat Endoleaks After EVAR: Tips And Tricks To Make Them Work |
Presenters(s):Jörn O. Balzer, MD, PhD | |
4:20 PM - 4:25 PM | The Truth About EVAR Surveillance From The European Survey Analysis: Is It Really A Good Thing? |
Presenters(s):Vicente Riambau, MD, PhD | |
4:26 PM - 4:31 PM | Duplex Ultrasound To Guide Treatment Of Popliteal Entrapment |
Presenters(s):Niten Singh, MD | |
4:32 PM - 4:37 PM | Clinical Importance Of Vein Graft Arterialization: How Good Is It; How Bad Can It Be? |
Presenters(s):Alan Dardik, MD, PhD | |
4:38 PM - 4:43 PM | Panel Discussion |
TOPICS PRESENTED BY TITLE: (SYNCHRONIZED TALKS, SLIDES AND ABSTRACTS THAT WILL BE AVAILABLE ON OUR WEB-BASED VERSION 5 WEEKS AFTER THE MEETING.) | |
Web-Based Presentation | 40.1 - Use Of Covered Palmaz Stent (VI-Maquet) For Solving Difficult Neck Problems |
Presenters(s):Afshin Assadian, MD | |
Web-Based Presentation | 40.2 - The European View Of CAS vs. CEA In Light Of All The Trials |
Presenters(s):Jan S. Brunkwall, MD, PhD | |
Web-Based Presentation | 40.3 - What Is The Best Technique For Measuring Intra-abdominal Pressure (IAP) And What Is The Relationship Between IAP And Colonic Perfusion? |
Presenters(s):Martin Björck, MD, PhD | |
Web-Based Presentation | 40.4 - Is EVAR Indicated For Aortoduodenal Fistulas? |
Presenters(s):Jacques Busquet, MD | |
Web-Based Presentation | 40.5 - AUI vs. Bifurcated Endografts For Treating Ruptured AAAs: Which Is Best? |
Presenters(s):Vicente Riambau, MD, PhD | |
END OF SESSION 40 | |
SESSION 41 SCHEDULE | |
Saturday
SESSION 41:
MORE UPDATES AND NEW TECHNOLOGY (5-MINUTE TALKS)
Moderators:Frank J. Veith, MD / Michael B. Silva, Jr., MD
|
|
x | |
4:44 PM - 4:49 PM | Improved Technique For Treating Vascular Graft Infection With An Endograft, Debridement And A VAC Dressing |
Presenters(s):Martin Björck, MD, PhD | |
4:50 PM - 4:55 PM | When Is Intervention Indicated For Restenosis After An Endovascular Treatment? |
Presenters(s):Joseph L. Mills, MD | |
4:56 PM - 5:01 PM | Do Outcomes Of Lower Extremity Revascularizations Differ In Men And Women? |
Presenters(s):Vivian Gahtan, MD | |
5:02 PM - 5:07 PM | After EVAR When Is “Fix It And Forget It”, i.e. No Surveillance An Acceptable Strategy? |
Presenters(s):Jean-Pierre Becquemin, MD, FRCS | |
5:08 PM - 5:13 PM | Correlates Of AAA Thrombus Thickness And Location With Endoleak After EVAR |
Presenters(s):Ali F. AbuRahma, MD | |
5:14 PM - 5:19 PM | Triple Fenestrated Endografts In The Treatment Of Juxtarenal AAAs: Advantages And Limitations |
Presenters(s):Peter L. Harris, MD, FRCS | |
5:20 PM - 5:25 PM | Through-The-Knee Amputation From A Posterior Approach: A Better Alternative Than Above-Knee Amputation |
Presenters(s):Carlos E. Donayre, MD | |
5:26 PM - 5:30 PM | Panel Discussion |
Moderator(s): Daniel G. Clair, MD / Mohan Adiseshiah, FRCS | |
5:30 PM - 5:35 PM | Tips And Tricks For Visceral Artery Stenting |
Presenters(s):Michael H. Wholey, MD, MBA | |
5:36 PM - 5:41 PM | Fast Track Concept Can Make Open Aortic Surgery Comparable To Endovascular And Laparoscopic Aortic Surgery |
Presenters(s):Sebastian E. Debus, MD, PhD | |
5:42 PM - 5:47 PM | Sphingosine-1-Phosphate (S-1-P) And VEGF Offer Promise For Effective Angiogenesis In CLI |
Presenters(s):Renan Uflacker, MD | |
5:48 PM - 5:53 PM | Hostile Neck Anatomy Is Less Of A Contraindication To EVAR With Newer Endografts Than It Was: What Are The New Limits For Acceptable Neck Angulation? |
Presenters(s):Hence J.M. Verhagen, MD, PhD | |
5:54 PM - 5:59 PM | Endovascular Repair Of Penetrating Atherosclerotic Ulcers In The Infrarenal Aorta And Iliac Arteries: When And How Should They Be Treated? |
Presenters(s):Afshin Assadian, MD | |
6:00 PM - 6:05 PM | Remote SFA Endarterectomy With The Moll Ring Cutter: Technique And Results |
Presenters(s):Jean-Paul deVries, MD, PhD | |
6:06 PM - 6:11 PM | Experience With The Use Of The Multilayer Stent For The Treatment Of Peripheral And Visceral Aneurysms |
Presenters(s):Claudio Rabbia, MD, PhD | |
6:12 PM - 6:17 PM | Panel Discussion |
TOPICS PRESENTED BY TITLE: (SYNCHRONIZED TALKS, SLIDES AND ABSTRACTS THAT WILL BE AVAILABLE ON OUR WEB-BASED VERSION 5 WEEKS AFTER THE MEETING.) | |
Web-Based Presentation | 41.1 - CO2 Angiography Is Simple And Safe: How To Do It Effectively: Techniques And Precautions |
Presenters(s):Kim J. Hodgson, MD | |
Web-Based Presentation | 41.2 - Bailout Options For Overstented Vital Aortic Branches |
Presenters(s):Martin Malina, MD, PhD | |
Web-Based Presentation | 41.3 - Molecular Mechanisms Of AAA Formation: An Update And Will There Ever Be Effective Medical Treatment? |
Presenters(s):Elliot L. Chaikof, MD, PhD | |
Web-Based Presentation | 41.4 - How To Set Up A Program Of Independent Neurological Evaluation For CAS Trials |
Presenters(s):Christopher J. Kwolek, MD | |
Web-Based Presentation | 41.5 - Antiplatelet Treatment For Secondary Risk Prevention In Vascular Patients: Which Drug, What Dose, How Long? |
Presenters(s):Russell H. Samson, MD, RVT, FACS | |
END OF SESSION 41 | |
Sunday, November 21, 2010
Print Entire 2010 Program:
|
|
SESSION 42 SCHEDULE | |
Sunday
SESSION 42:
NEW DEVELOPMENTS, CONCEPTS AND TECHNIQUES FOR EVALUATING CAROTID PLAQUES (5-MINUTE TALKS)
Moderators:Glenn Jacobowitz, MD / K. Wayne Johnston, MD, FRCS
|
|
x | |
6:45 AM - 6:50 AM | How To Make Ultrasound (Duplex) A Useful Surveillance Tool And Decrease The Number Of CTs After EVAR: Can Duplex Velocity Differences In Graft Limbs Indicate An Endoleak? |
Presenters(s):William D. Jordan, Jr., MD | |
6:51 AM - 6:56 AM | Immune Mediated Coagulopathy: A Complication Of Bovine Thrombin: How Can It Be Recognized, Prevented And Treated? |
Presenters(s):Fred A. Weaver, MD | |
6:57 AM - 7:02 AM | Inadvertent Arterial Injury Secondary To Treatment Of Varicose Veins And Venous Insufficiency By Surgery And Foam: Diagnosis And Treatment |
Presenters(s):Samy S. Nitecki, MD | |
7:03 AM - 7:08 AM | Practical Measures For Radiation Protection During Endovascular Procedures |
Presenters(s):Lindsay Machan, MD | |
7:09 AM - 7:14 AM | How To Manage Infected Carotid Patches |
Presenters(s):Mark D. Morasch, MD, FACS, FAHA, RPVI | |
7:15 AM - 7:20 AM | Computerized Models Of Displacement Forces Can Be Helpful In Predicting Migration Of Endografts After EVAR And Can Help In Graft Selection |
Presenters(s):Christopher K. Zarins, MD | |
7:21 AM - 7:26 AM | Standardized And Semiautomatic Noninvasive Evaluation Of Carotid Plaque Activity For Predicting Stroke Risk In Asymptomatic Patients: The Activity Index |
Presenters(s):Jose Fernandes e Fernandes, MD, PhD, FRCS (Eng), FACS | |
7:27 AM - 7:32 AM | Relationship Between Atherosclerotic Plaque Composition By IVUS And Cerebral Embolization |
Presenters(s):Carlos H. Timaran, MD | |
7:33 AM - 7:38 AM | New Techniques (PET And MSOT [Multispectral Optacoustic Tomography] Scanning) For Imaging Carotid Plaques To Determine Their Vulnerability To Have Strokes: Do They Work In Asymptomatic Patients? |
Presenters(s):Clark J. Zeebregts, MD, PhD | |
7:39 AM - 7:44 AM | Spinning Of CREST |
Presenters(s):Frank J. Veith, MD | |
7:45 AM - 7:50 AM | Contrast Enhanced Ultrasound To Identify Asymptomatic Carotid Plaques At Risk For Causing A Stroke |
Presenters(s):Alun H. Davies, MA, DM, FRCS, FHEA | |
7:51 AM - 7:56 AM | Carotid Plaque Composition Relates To Symptomatic Status Of Patients And The Incidence Of Restenosis: How Should Plaque Composition Influence Treatment? |
Presenters(s):Frans L. Moll, MD, PhD | |
7:57 AM - 8:02 AM | Can Asymptomatic Patients With Carotid Plaques Who Are At High Risk For Stroke Be Identified Noninvasively: The ACSRS Study In > 1,000 Patients |
Presenters(s):Andrew N. Nicolaides, MS, FRCS / George Geroulakos, MD, PhD | |
8:03 AM - 8:08 AM | Novel Technique For Assessing Plaque Risk Noninvasively In Patients With Asymptomatic Carotid Stenoses |
Presenters(s):Henrik Sillesen, MD, DMSc | |
8:09 AM - 8:13 AM | Panel Discussion |
TOPICS PRESENTED BY TITLE: (SYNCHRONIZED TALKS, SLIDES AND ABSTRACTS THAT WILL BE AVAILABLE ON OUR WEB-BASED VERSION 5 WEEKS AFTER THE MEETING.) | |
Web-Based Presentation | 42.1 - Predictors Of Mortality With Open And Endovascular Treatment Of Ruptured AAAs |
Presenters(s):Timur P. Sarac, MD | |
Web-Based Presentation | 42.2 - New Concepts In Effort Thrombosis And Neurogenic Thoracic Outlet Syndrome And How They Are Best Treated |
Presenters(s):Karl A. Illig, MD | |
Web-Based Presentation | 42.3 - C. Difficile Colitis Is Associated With Increased Mortality In All Vascular Surgery Patients |
Presenters(s):Caron B. Rockman, MD | |
Web-Based Presentation | 42.4 - Multilayer Stent For The Treatment Of Popliteal Aneurysms |
Presenters(s):Michel Henry, MD | |
Web-Based Presentation | 42.5 - CAS vs. CEA: Which Is Best For The Surgeon Who Can Do Both Well? |
Presenters(s):Ramon L. Varcoe, MD | |
Web-Based Presentation | 42.6 - CEA Or CAS Should Be Performed In The Acute Period After A TIA Or Minor Stroke Without Increasing Procedural Risk: How Can This Be Done Safely? |
Presenters(s):A. Ross Naylor, MD, FRCS | |
END OF SESSION 42 | |
SESSION 43 SCHEDULE | |
Sunday
SESSION 43:
MORE ABOUT ABDOMINAL AND THORACIC ANEURYSMS (5-MINUTE TALKS)
Moderators:Nicholas J. Morrissey, MD / Anton N. Sidawy, MD, MPH
|
|
x | |
8:18 AM - 8:23 AM | Use Of A Large Diameter, Low Profile (8 Fr Delivery System) Balloon Expandable Covered Stent (ADVANTA V12) For The Treatment Of Aortic Coarctation |
Presenters(s):Elchanan Bruckheimer, MBBS | |
8:24 AM - 8:29 AM | New Findings And Interpretations From The CAESAR Small AAA Trial |
Presenters(s):Piergiorgio Cao, MD, FRCS | |
8:30 AM - 8:35 AM | New Findings And Interpretations From The PIVOTAL Small AAA Trial |
Presenters(s):Kenneth Ouriel, MD, FACS, FACC | |
8:36 AM - 8:41 AM | The Strange Relationship Between Diabetes And AAAs |
Presenters(s):Frank A. Lederle, MD | |
8:42 AM - 8:47 AM | 10 Top Technical Tips For Performing EVAR With Challenging Anatomy |
Presenters(s):Zvonimir Krajcer, MD, FACC | |
8:48 AM - 8:53 AM | Predictors Of Poor Outcomes With EVAR Using NSQIP Database: How Can It Help Us Make Better Clinical Decisions? |
Presenters(s):Gregg S. Landis, MD | |
8:54 AM - 8:59 AM | Impact Of Obesity On Treatment Outcomes Of AAA Treatment With EVAR And Open Repair: Should Obesity Influence Choice Of Treatment Methods? |
Presenters(s):Anton N. Sidawy, MD, MPH | |
9:00 AM - 9:05 AM | Panel Discussion |
Moderator(s): Ralph G. DePalma, MD / Juan C. Parodi, MD | |
9:05 AM - 9:10 AM | Lessons Learned From Late Retreatment After EVAR Failure |
Presenters(s):Jon S. Matsumura, MD | |
9:11 AM - 9:16 AM | How Can Theoretical Mathematical And Bench Top Models Of Acute Aortic Dissection Be Helpful? |
Presenters(s):Ramon Berguer, MD, PhD | |
9:17 AM - 9:22 AM | When Can The Celiac Axis Be Covered Safely During TEVAR: Can There Be Adverse Outcomes And How Can They Be Predicted? |
Presenters(s):Manish Mehta, MD, MPH | |
9:23 AM - 9:28 AM | Debate 28: When The Left Subclavian Artery Is Covered In A TEVAR Procedure, It Must Be Revascularized: The SVS Guidelines Say So |
Presenters(s):Jon S. Matsumura, MD | |
9:29 AM - 9:34 AM | Debate 28: When The Left Subclavian Artery Is Covered In A TEVAR Procedure, It Should Only Be Revascularized Selectively |
Presenters(s):Timothy A. Resch, MD, PhD | |
9:35 AM - 9:40 AM | Significance Of Air Bubbles In An Aneurysm Sac After TEVAR Or EVAR: How Long Postop Can They Be A Normal Finding? |
Presenters(s):Frank J. Criado, MD, FACS, FSVM | |
9:41 AM - 9:46 AM | Minimal Incisionn Aortic Surgery: An Undertilized But Safe Technique |
Presenters(s):Manju Kalra, MBBS | |
9:47 AM - 9:55 AM | Panel Discussion Coffee Available In 3rd Floor Foyer |
TOPICS PRESENTED BY TITLE: (SYNCHRONIZED TALKS, SLIDES AND ABSTRACTS THAT WILL BE AVAILABLE ON OUR WEB-BASED VERSION 5 WEEKS AFTER THE MEETING.) | |
Web-Based Presentation | 43.1 - Current Guidelines For Treatment Of Small AAAs |
Presenters(s):Elliot L. Chaikof, MD, PhD | |
Web-Based Presentation | 43.2 - Debate: Most Type I Endoleaks Are Dangerous And Must Be Treated |
Presenters(s):Michel S. Makaroun, MD | |
Web-Based Presentation | 43.3 - Debate: Type I And Type II Endoleaks Are Not Always Dangerous And Some Can Be Observed: Under What Conditions? |
Presenters(s):Frans L. Moll, MD, PhD | |
END OF SESSION 43 | |
SESSION 44 SCHEDULE | |
Sunday
SESSION 44:
NEW DEVELOPMENTS IN DISEASES OF THE SUPRA-AORTIC TRUNKS, THE VERTEBRALS AND THE CAROTIDS (5-MINUTE TALKS)
Moderators:A. Ross Naylor, MD, FRCS / Evan C. Lipsitz, MD
|
|
x | |
9:56 AM - 10:01 AM | Optimal Treatment For Coincident Carotid Or Vertebral Stenosis And Concurrent High-Grade Intracranial Stenosis |
Presenters(s):Emmanuel M. Houdart, MD | |
10:02 AM - 10:07 AM | Identifying And Managing The Isolated Cerebral Hemisphere During CAS And CEA |
Presenters(s):Peter A. Schneider, MD | |
10:08 AM - 10:13 AM | Takayasu’s Disease Treatment Options: When Is Endovascular Treatment With Stenting Acceptable? |
Presenters(s):Young Wook Kim, MD | |
10:14 AM - 10:19 AM | Are Stent Fractures After Common Carotid And Innominate Stenting Frequent: When Do They Occur And What Should Be Done About Them? |
Presenters(s):Mark K. Eskandari, MD | |
10:20 AM - 10:25 AM | Long-Term Results Of Vertebral Artery Stenting For Symptomatic Ostial Stenoses: Value And Limitations |
Presenters(s):Dai-Do Do, MD | |
10:26 AM - 10:31 AM | Unusual Application Of Flow Reversal Embolic Protection With Vertebral And Other Lesions |
Presenters(s):Karthikeshwar Kasirajan, MD | |
10:32 AM - 10:37 AM | Can CEA Be Performed Safely On Patients Taking ASA, Plavix And/Or Coumadin Without Stopping The Drugs: Tips And Tricks |
Presenters(s):Timothy M. Sullivan, MD / Addi Rizvi, MD | |
10:38 AM - 10:43 AM | Nationwide US Outcomes For CEA And CAS: Are There Important Differences In Women vs. Men; In Those > 80 vs. Those < 80? |
Presenters(s):Caron B. Rockman, MD | |
10:44 AM - 10:49 AM | Have CEA Results Improved Since The Landmark Trials (NASCET, ACAS, Etc.) And Why? |
Presenters(s):Wesley S. Moore, MD | |
10:50 AM - 10:55 AM | Debate 29: There Is A Major Role For CAS In Europe And The USA After The Recent Trials |
Presenters(s):Marc R.H. van Sambeek, MD, PhD | |
10:56 AM - 11:01 AM | Debate 29: The Role Of CAS After The Recent Trials Should Be Minimal – Especially In Asymptomatic Patients |
Presenters(s):Peter R.F. Bell, MD, FRCS, DSC, KBE | |
11:02 AM - 11:08 AM | Panel Discussion |
TOPICS PRESENTED BY TITLE: (SYNCHRONIZED TALKS, SLIDES AND ABSTRACTS THAT WILL BE AVAILABLE ON OUR WEB-BASED VERSION 5 WEEKS AFTER THE MEETING.) | |
Web-Based Presentation | 44.1 - Correlation Of Carotid Stump Pressure With Collateral Cerebral Circulation |
Presenters(s):Ali F. AbuRahma, MD | |
Web-Based Presentation | 44.2 - Does Endovascular Treatment Of Takayasu’s Disease Ever Work And When? |
Presenters(s):Byung-Boong Lee, MD | |
END OF SESSION 44 | |
SESSION 45 SCHEDULE | |
Sunday
SESSION 45:
NEW DEVELOPMENTS IN CAS AND RELATED TECHNIQUES (5-MINUTE TALKS)
Moderators:Daniel G. Clair, MD / Giorgio M. Biasi, MD
|
|
x | |
11:09 AM - 11:14 AM | Why All The Landmark Trials Supporting CEA To Prevent Strokes From Carotid Stenosis Are Obsolete: When Is Carotid Intervention Indicated? |
Presenters(s):Anne L. Abbott, MD, PhD, FRACP | |
11:15 AM - 11:20 AM | Debate 30: CEA Not CAS Is The Best Treatment For Most Patients With High-Grade Carotid Stenosis |
Presenters(s):Roberto Chiesa, MD | |
11:21 AM - 11:26 AM | Debate 30: CAS Not CEA Is The Best Treatment For Most Patients With High Grade Carotid Stenosis |
Presenters(s):Piergiorgio Cao, MD, FRCS | |
11:27 AM - 11:32 AM | Debate 30: Best Medical Treatment (BMRX) Should Be The Treatment Of Choice For Most Patients With Asymptomatic Carotid Stenosis: They Do Not Require Prophylactic CEA Or CAS |
Presenters(s):A. Ross Naylor, MD, FRCS | |
11:33 AM - 11:38 AM | CAS vs. CEA: What Are The Relative Results For Symptomatic And Asymptomatic Patients From The SVS Registry? |
Presenters(s):Anton N. Sidawy, MD, MPH | |
11:39 AM - 11:44 AM | Debate 31: No Patient Should Undergo CAS Without Embolic Brain Protection |
Presenters(s):Sumaira Macdonald, MBChB (Comm), FRCP, FRCR, PhD | |
11:45 AM - 11:50 AM | Debate 31: Some Patients Should Undergo CAS Without Embolic Brain Protection |
Presenters(s):Franco Perona, MD | |
11:51 AM - 11:56 AM | CAS Is The Treatment Of Choice For Post CEA Symptomatic Restenosis: When Is Observation And Medical Treatment Indicated? |
Presenters(s):Ali F. AbuRahma, MD | |
11:57 AM - 12:08 PM | Panel Discussion / Refreshments Available In 3rd Floor Foyer |
Moderator(s): Michael B. Silva, Jr., MD / Anton N. Sidawy, MD, MPH | |
12:09 PM - 12:14 PM | Current Status Of Gra- Scale Median (GSM) For Detecting Asymptomatic Carotid Plaques At Risk For Causing Stroke: Why Is There Controversy About The Value Of GSM In Assessing Plaque Vulnerability And Risk? |
Presenters(s):Giorgio M. Biasi, MD | |
12:15 PM - 12:20 PM | Is There A Role For CAS In The Presence Of A Carotid String Sign? |
Presenters(s):Carlos H. Timaran, MD | |
12:21 PM - 12:26 PM | 10 Top Tips For CAS Without Complications |
Presenters(s):Ali Amin, MD, RVT, FACS, FACC | |
12:27 PM - 12:32 PM | Subanalysis Of Flow Reversal System (FRS) For Embolic Protection: What Lessons Can Be Learned? |
Presenters(s):Daniel G. Clair, MD | |
12:33 PM - 12:38 PM | Comparison Of Filters And Flow Reversal For Brain Protection As Monitored By TCD And DWI MRI |
Presenters(s):Claudio J. Schönholz, MD | |
12:39 PM - 12:44 PM | Why Were The Results Of CREST And ICSS So Different: Therapeutic Implications |
Presenters(s):Frans L. Moll, MD, PhD | |
12:45 PM - 12:50 PM | Analysis Of Filter Debris From CAS Procedures: Does It Correlate With Duplex GSM Findings And How Does It Help Choose The Best Means Of Embolic Protection? |
Presenters(s):Peter L. Faries, MD, FACS | |
12:51 PM - 12:56 PM | Carotid Stent Fractures: Incidence And Implications |
Presenters(s):Richard J. Powell, MD | |
12:57 PM - 1:02 PM | Open Surgical Technique Getting Exposure Of The ICA To The Base Of The Skull For Aneurysms, etc.: It's Better Than Dislocating The Jaw |
Presenters(s):Michel A. Bartoli, MD / Alain Branchereau, MD | |
1:03 PM - 1:10 PM | Panel Discussion |
Web-Based Presentation | 45.1 - How Can The CREST And ICSS Results Be Reconciled? |
Presenters(s):Christopher K. Zarins, MD | |
Web-Based Presentation | 45.2 - SVS CAS Registry Shows No Difference In Results Between Open And Closed Cell Stents |
Presenters(s):Gregorio A. Sicard, MD | |
END OF SESSION 45 | |
SESSION 46 SCHEDULE | |
Sunday
SESSION 46:
NEW CONCEPTS, ADVANCES, LATE BREAKING TRIALS AND DEVELOPMENTS (4-MINUTE TALKS)
Moderators:Gregorio A. Sicard, MD / William D. Suggs, MD
|
|
x | |
1:10 PM - 1:15 PM | Minimal Aortic Injury After Chest Trauma: Not All Patients Need Repair: A New Classification System |
Presenters(s):Benjamin W. Starnes, MD | |
1:15 PM - 1:19 PM | Current Thinking About The Biology Of AAAs: Is There Any Hope For Medical Treatment To Slow AAA Growth? |
Presenters(s):Matt M. Thompson, MD | |
1:20 PM - 1:24 PM | Leaving A Temporary Catheter In The AAA Sac After EVAR Permits Diagnosis And Treatment Of Type I And II Endoleaks |
Presenters(s):William J. Quinones-Baldrich, MD | |
1:25 PM - 1:29 PM | The Unballoon Aortic Dilating Device Improves Endograft Fixation Without Obstructing Flow Or Causing Graft Blow-Down |
Presenters(s):Venkatesh G. Ramaiah, MD | |
1:30 PM - 1:34 PM | Preop Variables Predict Which Type II Endoleak Will Persist And Require Reintervention |
Presenters(s):Glenn M. LaMuraglia, MD | |
1:35 PM - 1:39 PM | Improved Techniques For Treating Acute SMA Occlusions In The Endovascular Era |
Presenters(s):Martin Björck, MD, PhD | |
1:40 PM - 1:44 PM | A New Better Prosthetic Vascular Graft That Minimizes Suture Hole Bleeding |
Presenters(s):Hans-Henning Eckstein, MD, PhD | |
1:45 PM - 1:49 PM | What Is The Role For Controlled Hypotension During TEVAR? |
Presenters(s):W. Anthony Lee, MD | |
1:50 PM - 1:54 PM | The Pin-Down Technique For Crossover Access Via An Aortobifemoral Graft With A Sharp Angle |
Presenters(s):Sam S. Ahn, MD, FACS, MBA | |
1:55 PM - 1:59 PM | Long-Term Results Of VAC On Vessel And Prosthesis For The Treatment Of Arterial Graft Infection |
Presenters(s):Dieter O. Mayer, MD | |
2:00 PM - 2:06 PM | Panel Discussion |
TOPICS PRESENTED BY TITLE: (SYNCHRONIZED TALKS, SLIDES AND ABSTRACTS THAT WILL BE AVAILABLE ON OUR WEB-BASED VERSION 5 WEEKS AFTER THE MEETING.) | |
Web-Based Presentation | 46.1 - A New Simplified System For Measuring Internal Pressures Without A Hardwire Connection |
Presenters(s):Timur P. Sarac, MD | |
Web-Based Presentation | 46.2 - Improved Management Of Type II Endoleaks With Coil Embolization |
Presenters(s):Frank R. Arko, MD | |
Web-Based Presentation | 46.3 - Vascular Injuries From Laparoscopic Procedures: Diagnosis And Treatment |
Presenters(s):Samy S. Nitecki, MD | |
Web-Based Presentation | 46.4 - Advantages Of And Indications For Prasugrel Over Plavix For Platelet Inhibition: When Does It Matter? |
Presenters(s):Samuel R. Money, MD, MBA | |
Web-Based Presentation | 46.5 - A New Simplified System To Evacuate Toxic Blood From Ischemic Limbs To Prevent Reperfusion Syndrome After Relief Of Severe Acute Limb Ischemia |
Presenters(s):Florian Dick, MD | |
Web-Based Presentation | 46.6 - New Developments In Silver Acetate Impregnated Grafts For Use In Infected Fields |
Presenters(s):Max Zegelman, MD, PhD | |
END OF SESSION 46 | |
SESSION 47 SCHEDULE | |
Sunday
SESSION 47:
NEW CONCEPTS, RECENT ADVANCES AND DEVELOPMENTS (4-MINUTE TALKS)
|
|
x | |
2:07 PM - 2:11 PM | Tips And Tricks For Anterior Lumbar Spine Exposure |
Presenters(s):William J. Quinones-Baldrich, MD | |
2:12 PM - 2:16 PM | Advantages Of Stent-Grafts In TIPS Procedures |
Presenters(s):Ziv J. Haskal, MD, FACR, FAHA, FSIR | |
2:17 PM - 2:21 PM | Comparison Of Brain Microemboli Resulting From CAS With Flow Reversal And CEA |
Presenters(s):Karthikeshwar Kasirajan, MD | |
2:22 PM - 2:26 PM | New Biomarkers Of Activity Levels In Takayasu’s Arteritis: Can They Guide Treatment? |
Presenters(s):Xiaoyun Luo, MD / Qinghua Wu, MD | |
2:27 PM - 2:31 PM | Percutaneous Device (ROX) To Create An Iliac AV Fistula To Improve Oxygenation For Patients With Hypoxic COPD: Status Of European And U.S. Trials |
Presenters(s):David H. Deaton, MD | |
2:32 PM - 2:36 PM | Infrainguinal Bypass Surgery For CLI Has Lower Mortality And Morbidity Than Amputation In Risk Matched Patients |
Presenters(s):Michael Belkin, MD | |
2:37 PM - 2:41 PM | Sideways Movement Of Endografts Is Predictive Of Adverse Events |
Presenters(s):Christopher K. Zarins, MD | |
2:42 PM - 2:46 PM | In Lower Extremity Revascularization How Important Is Patency? |
Presenters(s):Richard F. Neville, MD | |
2:47 PM - 2:51 PM | How To Predict Which Patients With A Small AAA Are Likely To Require Treatment |
Presenters(s):K. Craig Kent, MD | |
2:52 PM - 2:56 PM | Promising Results Of A Spiral Flow Synthetic Vascular Graft: Theory And 2-Year Fem-Pop Results |
Presenters(s):Frank E.G. Vermassen, MD, PhD | |
2:57 PM - 3:01 PM | Is EVAR The Treatment Of Choice For Aortoenteric Fistulas: Review Of World Experience |
Presenters(s):Lars Lonn, MD, PhD | |
3:02 PM - 3:06 PM | The Best Way To Treat Aortoiliac Occlusive Disease Is To Create A New Aortic Bifurcation With Covered Balloon Expandable Stent-Grafts |
Presenters(s):Peter C.J. Goverde, MD | |
3:07 PM - 3:11 PM | Role Of PET/CT With FDG Uptake To Assess The Importance Of The Dynamic Inflammatory Process In Arteriosclerosis And How It Can Be Modified By Statins |
Presenters(s):Firas F. Mussa, MD | |
3:12 PM - 3:19 PM | Panel Discussion |
3:19 PM - 3:30 PM | Raffle Prize Drawing For Fully Paid Clinician Attendees. You Must Be Present To Win. |
3:30 PM - 3:30 PM | Symposium Ends. Come Back Next Year – November 16-20, 2011. |
Presenters(s): | |
TOPICS PRESENTED BY TITLE: (SYNCHRONIZED TALKS, SLIDES AND ABSTRACTS THAT WILL BE AVAILABLE ON OUR WEB-BASED VERSION 5 WEEKS AFTER THE MEETING.) | |
Web-Based Presentation | 47.1 - Is Arterial Compression Underestimated In TOS: Why And What Should Be Done About It? |
Presenters(s):Enrique Criado, MD, FACS | |
Web-Based Presentation | 47.2 - What Is The 30-Day, 1-Year And 5-Year Mortality For Open AAA Repair In A Northern European Population Based Study? Does Gender Matter? |
Presenters(s):Hence J.M. Verhagen, MD, PhD | |
Web-Based Presentation | 47.3 - Anatomic Fixation Of Endografts At The Aortic Bifurcation Enables EVAR Treatment Of Difficult Necks With Good Long-Term Results Without Migration |
Presenters(s):Jeffrey P. Carpenter, MD | |
Web-Based Presentation | 47.4 - Predictors Of Cardiac Morbidity And Mortality During EVAR |
Presenters(s):Ronald M. Fairman, MD | |
Web-Based Presentation | 47.5 - Endovascular Techniques To Improve Results With Open Repair For Ruptured AAAs |
Presenters(s):Dipankar Mukherjee, MD | |
END OF SESSION 47 | |